TY - JOUR AU - Hubbard, S. R. AU - Till, J. H. PY - 2000 DA - 2000// TI - Protein tyrosine kinase structure and function JO - Annu Rev Biochem VL - 69 UR - https://doi.org/10.1146/annurev.biochem.69.1.373 DO - 10.1146/annurev.biochem.69.1.373 ID - Hubbard2000 ER - TY - JOUR AU - Scheijen, B. AU - Griffin, J. D. PY - 2002 DA - 2002// TI - Tyrosine kinase oncogenes in normal hematopoiesis and hematological disease JO - Oncogene VL - 21 UR - https://doi.org/10.1038/sj.onc.1205317 DO - 10.1038/sj.onc.1205317 ID - Scheijen2002 ER - TY - JOUR AU - Chase, A. AU - Cross, N. C. PY - 2006 DA - 2006// TI - Signal transduction therapy in haematological malignancies: identification and targeting of tyrosine kinases JO - Clin Sci (Lond) VL - 111 UR - https://doi.org/10.1042/CS20060035 DO - 10.1042/CS20060035 ID - Chase2006 ER - TY - JOUR AU - Paul, M. K. AU - Mukhopadhyay, A. K. PY - 2004 DA - 2004// TI - Tyrosine kinase - Role and significance in Cancer JO - Int J Med Sci VL - 1 UR - https://doi.org/10.7150/ijms.1.101 DO - 10.7150/ijms.1.101 ID - Paul2004 ER - TY - JOUR AU - Kosior, K. AU - Lewandowska-Grygiel, M. AU - Giannopoulos, K. PY - 2011 DA - 2011// TI - Tyrosine kinase inhibitors in hematological malignancies JO - Postepy Hig Med Dosw (Online) VL - 65 UR - https://doi.org/10.5604/17322693.968778 DO - 10.5604/17322693.968778 ID - Kosior2011 ER - TY - JOUR AU - Wadleigh, M. AU - DeAngelo, D. J. AU - Griffin, J. D. AU - Stone, R. M. PY - 2005 DA - 2005// TI - After chronic myelogenous leukemia: tyrosine kinase inhibitors in other hematologic malignancies JO - Blood VL - 105 UR - https://doi.org/10.1182/blood-2003-11-3896 DO - 10.1182/blood-2003-11-3896 ID - Wadleigh2005 ER - TY - JOUR AU - Rossi, J. F. PY - 2015 DA - 2015// TI - Targeted Therapies in Adult B-Cell Malignancies JO - Biomed Res Int VL - 2015 ID - Rossi2015 ER - TY - JOUR AU - Al-Obeidi, F. A. AU - Lam, K. S. PY - 2000 DA - 2000// TI - Development of inhibitors for protein tyrosine kinases JO - Oncogene VL - 19 UR - https://doi.org/10.1038/sj.onc.1203926 DO - 10.1038/sj.onc.1203926 ID - Al-Obeidi2000 ER - TY - JOUR AU - Lahiry, P. AU - Torkamani, A. AU - Schork, N. J. AU - Hegele, R. A. PY - 2010 DA - 2010// TI - Kinase mutations in human disease: interpreting genotype–phenotype relationships JO - Nat Rev Genet VL - 11 UR - https://doi.org/10.1038/nrg2707 DO - 10.1038/nrg2707 ID - Lahiry2010 ER - TY - JOUR AU - Johnson, G. L. AU - Lapadat, R. PY - 2002 DA - 2002// TI - Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases JO - Science VL - 298 UR - https://doi.org/10.1126/science.1072682 DO - 10.1126/science.1072682 ID - Johnson2002 ER - TY - JOUR AU - Pawson, T. PY - 2002 DA - 2002// TI - Regulation and targets of receptor tyrosine kinases JO - Eur J Cancer VL - 38 UR - https://doi.org/10.1016/S0959-8049(02)80597-4 DO - 10.1016/S0959-8049(02)80597-4 ID - Pawson2002 ER - TY - JOUR AU - Heinrich, P. C. AU - Behrmann, I. AU - Haan, S. AU - Hermanns, H. M. AU - Muller-Newen, G. AU - Schaper, F. PY - 2003 DA - 2003// TI - Principles of interleukin (IL)-6-type cytokine signalling and its regulation JO - Biochem J VL - 374 UR - https://doi.org/10.1042/bj20030407 DO - 10.1042/bj20030407 ID - Heinrich2003 ER - TY - JOUR AU - Welch, P. J. AU - Wang, J. Y. PY - 1993 DA - 1993// TI - A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle JO - Cell VL - 75 UR - https://doi.org/10.1016/0092-8674(93)90497-E DO - 10.1016/0092-8674(93)90497-E ID - Welch1993 ER - TY - JOUR AU - Yin, B. PY - 2011 DA - 2011// TI - Focal adhesion kinase as a target in the treatment of hematological malignancies JO - Leuk Res VL - 35 UR - https://doi.org/10.1016/j.leukres.2011.04.017 DO - 10.1016/j.leukres.2011.04.017 ID - Yin2011 ER - TY - JOUR AU - Elias, D. AU - Ditzel, H. J. PY - 2015 DA - 2015// TI - Fyn is an important molecule in cancer pathogenesis and drug resistance JO - Pharmacol Res VL - 100 UR - https://doi.org/10.1016/j.phrs.2015.08.010 DO - 10.1016/j.phrs.2015.08.010 ID - Elias2015 ER - TY - JOUR AU - Prieto-Echague, V. AU - Miller, W. T. PY - 2011 DA - 2011// TI - Regulation of ack-family nonreceptor tyrosine kinases JO - J Signal Transduct VL - 2011 UR - https://doi.org/10.1155/2011/742372 DO - 10.1155/2011/742372 ID - Prieto-Echague2011 ER - TY - JOUR AU - Jacobs, S. AU - Hansen, F. AU - Kasl, S. AU - Ostfeld, A. AU - Berkman, L. AU - Kim, K. PY - 1990 DA - 1990// TI - Anxiety disorders during acute bereavement: risk and risk factors JO - J Clin Psychiatry VL - 51 ID - Jacobs1990 ER - TY - JOUR AU - Mano, H. PY - 1999 DA - 1999// TI - Tec family of protein-tyrosine kinases: an overview of their structure and function JO - Cytokine Growth Factor Rev VL - 10 UR - https://doi.org/10.1016/S1359-6101(99)00019-2 DO - 10.1016/S1359-6101(99)00019-2 ID - Mano1999 ER - TY - JOUR AU - Futterer, K. AU - Wong, J. AU - Grucza, R. A. AU - Chan, A. C. AU - Waksman, G. PY - 1998 DA - 1998// TI - Structural basis for Syk tyrosine kinase ubiquity in signal transduction pathways revealed by the crystal structure of its regulatory SH2 domains bound to a dually phosphorylated ITAM peptide JO - J Mol Biol VL - 281 UR - https://doi.org/10.1006/jmbi.1998.1964 DO - 10.1006/jmbi.1998.1964 ID - Futterer1998 ER - TY - JOUR AU - Mocsai, A. AU - Ruland, J. AU - Tybulewicz, V. L. PY - 2010 DA - 2010// TI - The SYK tyrosine kinase: a crucial player in diverse biological functions JO - Nat Rev Immunol VL - 10 UR - https://doi.org/10.1038/nri2765 DO - 10.1038/nri2765 ID - Mocsai2010 ER - TY - JOUR AU - Geahlen, R. L. PY - 2009 DA - 2009// TI - Syk and pTyr'd: Signaling through the B cell antigen receptor JO - Biochim Biophys Acta VL - 1793 UR - https://doi.org/10.1016/j.bbamcr.2009.03.004 DO - 10.1016/j.bbamcr.2009.03.004 ID - Geahlen2009 ER - TY - JOUR AU - Schenk, P. W. AU - Snaar-Jagalska, B. E. PY - 1999 DA - 1999// TI - Signal perception and transduction: the role of protein kinases JO - Biochim Biophys Acta VL - 1449 UR - https://doi.org/10.1016/S0167-4889(98)00178-5 DO - 10.1016/S0167-4889(98)00178-5 ID - Schenk1999 ER - TY - JOUR AU - Heldin, C. H. PY - 1995 DA - 1995// TI - Dimerization of cell surface receptors in signal transduction JO - Cell VL - 80 UR - https://doi.org/10.1016/0092-8674(95)90404-2 DO - 10.1016/0092-8674(95)90404-2 ID - Heldin1995 ER - TY - JOUR AU - Edelman, A. M. AU - Blumenthal, D. K. AU - Krebs, E. G. PY - 1987 DA - 1987// TI - Protein serine/threonine kinases JO - Annu Rev Biochem VL - 56 UR - https://doi.org/10.1146/annurev.bi.56.070187.003031 DO - 10.1146/annurev.bi.56.070187.003031 ID - Edelman1987 ER - TY - JOUR AU - Capra, M. AU - Nuciforo, P. G. AU - Confalonieri, S. AU - Quarto, M. AU - Bianchi, M. AU - Nebuloni, M. AU - Boldorini, R. AU - Pallotti, F. AU - Viale, G. AU - Gishizky, M. L. PY - 2006 DA - 2006// TI - Frequent alterations in the expression of serine/threonine kinases in human cancers JO - Cancer Res VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-05-3489 DO - 10.1158/0008-5472.CAN-05-3489 ID - Capra2006 ER - TY - JOUR AU - Guicciardi, M. E. AU - Gores, G. J. PY - 2003 DA - 2003// TI - AIP1: a new player in TNF signaling JO - J Clin Invest VL - 111 UR - https://doi.org/10.1172/JCI200318911 DO - 10.1172/JCI200318911 ID - Guicciardi2003 ER - TY - JOUR AU - Chalandon, Y. AU - Schwaller, J. PY - 2005 DA - 2005// TI - Targeting mutated protein tyrosine kinases and their signaling pathways in hematologic malignancies JO - Haematologica VL - 90 ID - Chalandon2005 ER - TY - JOUR AU - Sirvent, A. AU - Benistant, C. AU - Roche, S. PY - 2008 DA - 2008// TI - Cytoplasmic signalling by the c-Abl tyrosine kinase in normal and cancer cells JO - Biol Cell VL - 100 UR - https://doi.org/10.1042/BC20080020 DO - 10.1042/BC20080020 ID - Sirvent2008 ER - TY - JOUR AU - Wang, J. AU - Pendergast, A. M. PY - 2015 DA - 2015// TI - The emerging role of ABL kinases in solid tumors JO - Trends in cancer VL - 1 UR - https://doi.org/10.1016/j.trecan.2015.07.004 DO - 10.1016/j.trecan.2015.07.004 ID - Wang2015 ER - TY - JOUR AU - Antoku, S. AU - Saksela, K. AU - Rivera, G. M. AU - Mayer, B. J. PY - 2008 DA - 2008// TI - Essential role of c-Abl PxxP motifs and its interactions with Crk and Nck adaptors in cell spreading JO - J Cell Sci VL - 121 UR - https://doi.org/10.1242/jcs.031575 DO - 10.1242/jcs.031575 ID - Antoku2008 ER - TY - JOUR AU - Hantschel, O. PY - 2012 DA - 2012// TI - Structure, regulation, signaling, and targeting of abl kinases in cancer JO - Genes & cancer VL - 3 UR - https://doi.org/10.1177/1947601912458584 DO - 10.1177/1947601912458584 ID - Hantschel2012 ER - TY - JOUR AU - Greuber, E. K. AU - Smith-Pearson, P. AU - Wang, J. AU - Pendergast, A. M. PY - 2013 DA - 2013// TI - Role of ABL family kinases in cancer: from leukaemia to solid tumours JO - Nat Rev Cancer VL - 13 UR - https://doi.org/10.1038/nrc3563 DO - 10.1038/nrc3563 ID - Greuber2013 ER - TY - JOUR AU - Colicelli, J. PY - 2010 DA - 2010// TI - ABL tyrosine kinases: evolution of function, regulation, and specificity JO - Sci Signal VL - 3 UR - https://doi.org/10.1126/scisignal.3139re6 DO - 10.1126/scisignal.3139re6 ID - Colicelli2010 ER - TY - JOUR AU - Khatri, A. AU - Wang, J. AU - Pendergast, A. M. PY - 2016 DA - 2016// TI - Multifunctional Abl kinases in health and disease JO - J Cell Sci VL - 129 UR - https://doi.org/10.1242/jcs.175521 DO - 10.1242/jcs.175521 ID - Khatri2016 ER - TY - JOUR AU - Pluk, H. AU - Dorey, K. AU - Superti-Furga, G. PY - 2002 DA - 2002// TI - Autoinhibition of c-Abl JO - Cell VL - 108 UR - https://doi.org/10.1016/S0092-8674(02)00623-2 DO - 10.1016/S0092-8674(02)00623-2 ID - Pluk2002 ER - TY - JOUR AU - Chen, S. AU - O'Reilly, L. P. AU - Smithgall, T. E. AU - Engen, J. R. PY - 2008 DA - 2008// TI - Tyrosine phosphorylation in the SH3 domain disrupts negative regulatory interactions within the c-Abl kinase core JO - J Mol Biol VL - 383 UR - https://doi.org/10.1016/j.jmb.2008.08.040 DO - 10.1016/j.jmb.2008.08.040 ID - Chen2008 ER - TY - JOUR AU - Cao, C. AU - Li, Y. AU - Leng, Y. AU - Li, P. AU - Ma, Q. AU - Kufe, D. PY - 2005 DA - 2005// TI - Ubiquitination and degradation of the Arg tyrosine kinase is regulated by oxidative stress JO - Oncogene VL - 24 UR - https://doi.org/10.1038/sj.onc.1208454 DO - 10.1038/sj.onc.1208454 ID - Cao2005 ER - TY - JOUR AU - Meyn, M. A. AU - Wilson, M. B. AU - Abdi, F. A. AU - Fahey, N. AU - Schiavone, A. P. AU - Wu, J. AU - Hochrein, J. M. AU - Engen, J. R. AU - Smithgall, T. E. PY - 2006 DA - 2006// TI - Src family kinases phosphorylate the Bcr-Abl SH3-SH2 region and modulate Bcr-Abl transforming activity JO - J Biol Chem VL - 281 UR - https://doi.org/10.1074/jbc.M605902200 DO - 10.1074/jbc.M605902200 ID - Meyn2006 ER - TY - JOUR AU - Li, S. AU - Ilaria, R. L. AU - Million, R. P. AU - Daley, G. Q. AU - Van Etten, R. A. PY - 1999 DA - 1999// TI - The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia–like syndrome in mice but have different lymphoid leukemogenic activity JO - J Exp Med VL - 189 UR - https://doi.org/10.1084/jem.189.9.1399 DO - 10.1084/jem.189.9.1399 ID - Li1999 ER - TY - JOUR AU - Advani, A. S. AU - Pendergast, A. M. PY - 2002 DA - 2002// TI - Bcr–Abl variants: biological and clinical aspects JO - Leuk Res VL - 26 UR - https://doi.org/10.1016/S0145-2126(01)00197-7 DO - 10.1016/S0145-2126(01)00197-7 ID - Advani2002 ER - TY - JOUR AU - Panjarian, S. AU - Iacob, R. E. AU - Chen, S. AU - Engen, J. R. AU - Smithgall, T. E. PY - 2013 DA - 2013// TI - Structure and dynamic regulation of Abl kinases JO - J Biol Chem VL - 288 UR - https://doi.org/10.1074/jbc.R112.438382 DO - 10.1074/jbc.R112.438382 ID - Panjarian2013 ER - TY - JOUR AU - Lamontanara, A. J. AU - Georgeon, S. AU - Tria, G. AU - Svergun, D. I. AU - Hantschel, O. PY - 2014 DA - 2014// TI - The SH2 domain of Abl kinases regulates kinase autophosphorylation by controlling activation loop accessibility JO - Nat Commun VL - 5 UR - https://doi.org/10.1038/ncomms6470 DO - 10.1038/ncomms6470 ID - Lamontanara2014 ER - TY - JOUR AU - Hantschel, O. AU - Warsch, W. AU - Eckelhart, E. AU - Kaupe, I. AU - Grebien, F. AU - Wagner, K. -. U. AU - Superti-Furga, G. AU - Sexl, V. PY - 2012 DA - 2012// TI - BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia JO - Nat Chem Biol VL - 8 UR - https://doi.org/10.1038/nchembio.775 DO - 10.1038/nchembio.775 ID - Hantschel2012 ER - TY - BOOK AU - Leoni, V. AU - Biondi, A. PY - 2015 DA - 2015// TI - Tyrosine kinase inhibitors in BCR-ABL positive acute lymphoblastic leukemia ID - Leoni2015 ER - TY - JOUR AU - Gopal, M. M. AU - Kotwal, J. AU - Kapoor, R. PY - 2014 DA - 2014// TI - Acute Myeloid Leukemia with BCR/ABL Fusion Chimera JO - Indian J Hematol Blood Transfusion VL - 30 UR - https://doi.org/10.1007/s12288-014-0359-3 DO - 10.1007/s12288-014-0359-3 ID - Gopal2014 ER - TY - JOUR AU - Soupir, C. P. AU - Vergilio, J. -. A. AU - Cin, P. D. AU - Muzikansky, A. AU - Kantarjian, H. AU - Jones, D. AU - Hasserjian, R. P. PY - 2007 DA - 2007// TI - Philadelphia chromosome–positive acute myeloid leukemia: a rare aggressive leukemia with clinicopathologic features distinct from chronic myeloid leukemia in myeloid blast crisis JO - Am J Clin Pathol VL - 127 UR - https://doi.org/10.1309/B4NVER1AJJ84CTUU DO - 10.1309/B4NVER1AJJ84CTUU ID - Soupir2007 ER - TY - JOUR AU - Li, J. AU - Smithgall, T. E. PY - 1998 DA - 1998// TI - Fibroblast transformation by Fps/Fes tyrosine kinases requires Ras, Rac, and Cdc42 and induces extracellular signal-regulated and c-Jun N-terminal kinase activation JO - J Biol Chem VL - 273 UR - https://doi.org/10.1074/jbc.273.22.13828 DO - 10.1074/jbc.273.22.13828 ID - Li1998 ER - TY - JOUR AU - Voisset, E. AU - Lopez, S. AU - Dubreuil, P. AU - De Sepulveda, P. PY - 2007 DA - 2007// TI - The tyrosine kinase FES is an essential effector of KIT D816V proliferation signal JO - Blood VL - 110 UR - https://doi.org/10.1182/blood-2007-02-076471 DO - 10.1182/blood-2007-02-076471 ID - Voisset2007 ER - TY - JOUR AU - Hellwig, S. AU - Miduturu, C. V. AU - Kanda, S. AU - Zhang, J. AU - Filippakopoulos, P. AU - Salah, E. AU - Deng, X. AU - Choi, H. G. AU - Zhou, W. AU - Hur, W. PY - 2012 DA - 2012// TI - Small-molecule inhibitors of the c-Fes protein-tyrosine kinase JO - Chem Biol VL - 19 UR - https://doi.org/10.1016/j.chembiol.2012.01.020 DO - 10.1016/j.chembiol.2012.01.020 ID - Hellwig2012 ER - TY - JOUR AU - Condorelli, F. AU - Stec-Martyna, E. AU - Zaborowska, J. AU - Felli, L. AU - Gemmi, I. AU - Ponassi, M. AU - Rosano, C. PY - 2011 DA - 2011// TI - Role of the non-receptor tyrosine kinase fes in cancer JO - Curr Med Chem VL - 18 UR - https://doi.org/10.2174/092986711796150522 DO - 10.2174/092986711796150522 ID - Condorelli2011 ER - TY - JOUR AU - Sangrar, W. AU - Zirgnibl, R. A. AU - Gao, Y. AU - Muller, W. J. AU - Jia, Z. AU - Greer, P. A. PY - 2005 DA - 2005// TI - An identity crisis for fps/fes: oncogene or tumor suppressor? JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-04-3468 DO - 10.1158/0008-5472.CAN-04-3468 ID - Sangrar2005 ER - TY - JOUR AU - Voisset, E. AU - Lopez, S. AU - Chaix, A. AU - Georges, C. AU - Hanssens, K. AU - Prebet, T. AU - Dubreuil, P. AU - De Sepulveda, P. PY - 2010 DA - 2010// TI - FES kinases are required for oncogenic FLT3 signaling JO - Leukemia VL - 24 UR - https://doi.org/10.1038/leu.2009.301 DO - 10.1038/leu.2009.301 ID - Voisset2010 ER - TY - JOUR AU - Feldman, R. A. AU - Lowy, D. R. AU - Vass, W. C. AU - Velu, T. J. PY - 1989 DA - 1989// TI - A highly efficient retroviral vector allows detection of the transforming activity of the human c-fps/fes proto-oncogene JO - J Virol VL - 63 ID - Feldman1989 ER - TY - JOUR AU - Furqan, M. AU - Mukhi, N. AU - Lee, B. AU - Liu, D. PY - 2013 DA - 2013// TI - Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application JO - Biomark Res VL - 1 UR - https://doi.org/10.1186/2050-7771-1-5 DO - 10.1186/2050-7771-1-5 ID - Furqan2013 ER - TY - JOUR AU - Haan, C. AU - Is'harc, H. AU - Hermanns, H. M. AU - Schmitz-Van De Leur, H. AU - Kerr, I. M. AU - Heinrich, P. C. AU - Grotzinger, J. AU - Behrmann, I. PY - 2001 DA - 2001// TI - Mapping of a region within the N terminus of Jak1 involved in cytokine receptor interaction JO - J Biol Chem VL - 276 UR - https://doi.org/10.1074/jbc.M106135200 DO - 10.1074/jbc.M106135200 ID - Haan2001 ER - TY - JOUR AU - Wilks, A. F. PY - 2008 DA - 2008// TI - The JAK kinases: not just another kinase drug discovery target JO - Semin Cell Dev Biol VL - 19 UR - https://doi.org/10.1016/j.semcdb.2008.07.020 DO - 10.1016/j.semcdb.2008.07.020 ID - Wilks2008 ER - TY - JOUR AU - O'Shea, J. J. AU - Schwartz, D. M. AU - Villarino, A. V. AU - Gadina, M. AU - McInnes, I. B. AU - Laurence, A. PY - 2015 DA - 2015// TI - The JAK-STAT pathway: impact on human disease and therapeutic intervention JO - Annu Rev Med VL - 66 UR - https://doi.org/10.1146/annurev-med-051113-024537 DO - 10.1146/annurev-med-051113-024537 ID - O'Shea2015 ER - TY - JOUR AU - Levine, R. L. AU - Gilliland, D. G. PY - 2007 DA - 2007// TI - JAK-2 mutations and their relevance to myeloproliferative disease JO - Curr Opin Hematol VL - 14 UR - https://doi.org/10.1097/00062752-200701000-00009 DO - 10.1097/00062752-200701000-00009 ID - Levine2007 ER - TY - JOUR AU - Springuel, L. AU - Renauld, J. C. AU - Knoops, L. PY - 2015 DA - 2015// TI - JAK kinase targeting in hematologic malignancies: a sinuous pathway from identification of genetic alterations towards clinical indications JO - Haematologica VL - 100 UR - https://doi.org/10.3324/haematol.2015.132142 DO - 10.3324/haematol.2015.132142 ID - Springuel2015 ER - TY - JOUR AU - Valentino, L. AU - Pierre, J. PY - 2006 DA - 2006// TI - JAK/STAT signal transduction: regulators and implication in hematological malignancies JO - Biochem Pharmacol VL - 71 UR - https://doi.org/10.1016/j.bcp.2005.12.017 DO - 10.1016/j.bcp.2005.12.017 ID - Valentino2006 ER - TY - JOUR AU - Carter-Su, C. AU - Smit, L. S. PY - 1998 DA - 1998// TI - Signaling via JAK tyrosine kinases: growth hormone receptor as a model system JO - Recent Prog Horm Res VL - 53 ID - Carter-Su1998 ER - TY - JOUR AU - Vainchenker, W. AU - Constantinescu, S. PY - 2013 DA - 2013// TI - JAK/STAT signaling in hematological malignancies JO - Oncogene VL - 32 UR - https://doi.org/10.1038/onc.2012.347 DO - 10.1038/onc.2012.347 ID - Vainchenker2013 ER - TY - JOUR AU - Vera, J. AU - Rateitschak, K. AU - Lange, F. AU - Kossow, C. AU - Wolkenhauer, O. AU - Jaster, R. PY - 2011 DA - 2011// TI - Systems biology of JAK-STAT signalling in human malignancies JO - Prog Biophys Mol Biol VL - 106 UR - https://doi.org/10.1016/j.pbiomolbio.2011.06.013 DO - 10.1016/j.pbiomolbio.2011.06.013 ID - Vera2011 ER - TY - JOUR AU - Constantinescu, S. N. AU - Girardot, M. AU - Pecquet, C. PY - 2008 DA - 2008// TI - Mining for JAK-STAT mutations in cancer JO - Trends Biochem Sci VL - 33 UR - https://doi.org/10.1016/j.tibs.2007.12.002 DO - 10.1016/j.tibs.2007.12.002 ID - Constantinescu2008 ER - TY - JOUR AU - Jeong, E. G. AU - Kim, M. S. AU - Nam, H. K. AU - Min, C. K. AU - Lee, S. AU - Chung, Y. J. AU - Yoo, N. J. AU - Lee, S. H. PY - 2008 DA - 2008// TI - Somatic mutations of JAK1 and JAK3 in acute leukemias and solid cancers JO - Clin Cancer Res VL - 14 UR - https://doi.org/10.1158/1078-0432.CCR-07-4839 DO - 10.1158/1078-0432.CCR-07-4839 ID - Jeong2008 ER - TY - JOUR AU - Baxter, E. J. AU - Scott, L. M. AU - Campbell, P. J. AU - East, C. AU - Fourouclas, N. AU - Swanton, S. AU - Vassiliou, G. S. AU - Bench, A. J. AU - Boyd, E. M. AU - Curtin, N. PY - 2005 DA - 2005// TI - Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders JO - Lancet VL - 365 UR - https://doi.org/10.1016/S0140-6736(05)74230-6 DO - 10.1016/S0140-6736(05)74230-6 ID - Baxter2005 ER - TY - JOUR AU - Hornakova, T. AU - Chiaretti, S. AU - Lemaire, M. M. AU - Foa, R. AU - Ben Abdelali, R. AU - Asnafi, V. AU - Tartaglia, M. AU - Renauld, J. C. AU - Knoops, L. PY - 2010 DA - 2010// TI - ALL-associated JAK1 mutations confer hypersensitivity to the antiproliferative effect of type I interferon JO - Blood VL - 115 UR - https://doi.org/10.1182/blood-2009-09-245498 DO - 10.1182/blood-2009-09-245498 ID - Hornakova2010 ER - TY - JOUR AU - Xiang, Z. AU - Zhao, Y. AU - Mitaksov, V. AU - Fremont, D. H. AU - Kasai, Y. AU - Molitoris, A. AU - Ries, R. E. AU - Miner, T. L. AU - McLellan, M. D. AU - DiPersio, J. F. PY - 2008 DA - 2008// TI - Identification of somatic JAK1 mutations in patients with acute myeloid leukemia JO - Blood VL - 111 UR - https://doi.org/10.1182/blood-2007-05-090308 DO - 10.1182/blood-2007-05-090308 ID - Xiang2008 ER - TY - JOUR AU - Flex, E. AU - Petrangeli, V. AU - Stella, L. AU - Chiaretti, S. AU - Hornakova, T. AU - Knoops, L. AU - Ariola, C. AU - Fodale, V. AU - Clappier, E. AU - Paoloni, F. PY - 2008 DA - 2008// TI - Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia JO - J Exp Med VL - 205 UR - https://doi.org/10.1084/jem.20072182 DO - 10.1084/jem.20072182 ID - Flex2008 ER - TY - JOUR AU - Mullighan, C. G. AU - Zhang, J. AU - Harvey, R. C. AU - Collins-Underwood, J. R. AU - Schulman, B. A. AU - Phillips, L. A. AU - Tasian, S. K. AU - Loh, M. L. AU - Su, X. AU - Liu, W. PY - 2009 DA - 2009// TI - JAK mutations in high-risk childhood acute lymphoblastic leukemia JO - Proc Natl Acad Sci U S A VL - 106 UR - https://doi.org/10.1073/pnas.0811761106 DO - 10.1073/pnas.0811761106 ID - Mullighan2009 ER - TY - JOUR AU - Tefferi, A. PY - 2008 DA - 2008// TI - JAK and MPL mutations in myeloid malignancies JO - Leuk Lymphoma VL - 49 UR - https://doi.org/10.1080/10428190801895360 DO - 10.1080/10428190801895360 ID - Tefferi2008 ER - TY - JOUR AU - Sakaguchi, H. AU - Okuno, Y. AU - Muramatsu, H. AU - Yoshida, K. AU - Shiraishi, Y. AU - Takahashi, M. AU - Kon, A. AU - Sanada, M. AU - Chiba, K. AU - Tanaka, H. PY - 2013 DA - 2013// TI - Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia JO - Nat Genet VL - 45 UR - https://doi.org/10.1038/ng.2698 DO - 10.1038/ng.2698 ID - Sakaguchi2013 ER - TY - JOUR AU - Walters, D. K. AU - Mercher, T. AU - Gu, T. L. AU - O'Hare, T. AU - Tyner, J. W. AU - Loriaux, M. AU - Goss, V. L. AU - Lee, K. A. AU - Eide, C. A. AU - Wong, M. J. PY - 2006 DA - 2006// TI - Activating alleles of JAK3 in acute megakaryoblastic leukemia JO - Cancer Cell VL - 10 UR - https://doi.org/10.1016/j.ccr.2006.06.002 DO - 10.1016/j.ccr.2006.06.002 ID - Walters2006 ER - TY - JOUR AU - Bouchekioua, A. AU - Scourzic, L. AU - De Wever, O. AU - Zhang, Y. AU - Cervera, P. AU - Aline-Fardin, A. AU - Mercher, T. AU - Gaulard, P. AU - Nyga, R. AU - Jeziorowska, D. PY - 2014 DA - 2014// TI - JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma JO - Leukemia VL - 28 UR - https://doi.org/10.1038/leu.2013.157 DO - 10.1038/leu.2013.157 ID - Bouchekioua2014 ER - TY - JOUR AU - Bains, T. AU - Heinrich, M. C. AU - Loriaux, M. M. AU - Beadling, C. AU - Nelson, D. AU - Warrick, A. AU - Neff, T. L. AU - Tyner, J. W. AU - Dunlap, J. AU - Corless, C. L. AU - Fan, G. PY - 2012 DA - 2012// TI - Newly described activating JAK3 mutations in T-cell acute lymphoblastic leukemia JO - Leukemia VL - 26 UR - https://doi.org/10.1038/leu.2012.74 DO - 10.1038/leu.2012.74 ID - Bains2012 ER - TY - JOUR AU - Sanda, T. AU - Tyner, J. W. AU - Gutierrez, A. AU - Ngo, V. N. AU - Glover, J. AU - Chang, B. H. AU - Yost, A. AU - Ma, W. AU - Fleischman, A. G. AU - Zhou, W. PY - 2013 DA - 2013// TI - TYK2-STAT1-BCL2 pathway dependence in T-cell acute lymphoblastic leukemia JO - Cancer Discov VL - 3 UR - https://doi.org/10.1158/2159-8290.CD-12-0504 DO - 10.1158/2159-8290.CD-12-0504 ID - Sanda2013 ER - TY - JOUR AU - Joos, S. AU - Kupper, M. AU - Ohl, S. AU - von Bonin, F. AU - Mechtersheimer, G. AU - Bentz, M. AU - Marynen, P. AU - Moller, P. AU - Pfreundschuh, M. AU - Trumper, L. AU - Lichter, P. PY - 2000 DA - 2000// TI - Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells JO - Cancer Res VL - 60 ID - Joos2000 ER - TY - JOUR AU - Rosenwald, A. AU - Wright, G. AU - Leroy, K. AU - Yu, X. AU - Gaulard, P. AU - Gascoyne, R. D. AU - Chan, W. C. AU - Zhao, T. AU - Haioun, C. AU - Greiner, T. C. PY - 2003 DA - 2003// TI - Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma JO - J Exp Med VL - 198 UR - https://doi.org/10.1084/jem.20031074 DO - 10.1084/jem.20031074 ID - Rosenwald2003 ER - TY - JOUR AU - Lenz, G. AU - Wright, G. W. AU - Emre, N. C. AU - Kohlhammer, H. AU - Dave, S. S. AU - Davis, R. E. AU - Carty, S. AU - Lam, L. T. AU - Shaffer, A. L. AU - Xiao, W. PY - 2008 DA - 2008// TI - Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways JO - Proc Natl Acad Sci U S A VL - 105 UR - https://doi.org/10.1073/pnas.0804295105 DO - 10.1073/pnas.0804295105 ID - Lenz2008 ER - TY - JOUR AU - Manser, E. AU - Leung, T. AU - Salihuddin, H. AU - Tan, L. AU - Lim, L. PY - 1993 DA - 1993// TI - A non-receptor tyrosine kinase that inhibits the GTPase activity of p21cdc42 JO - Nature VL - 363 UR - https://doi.org/10.1038/363364a0 DO - 10.1038/363364a0 ID - Manser1993 ER - TY - JOUR AU - Mahajan, K. AU - Mahajan, N. P. PY - 2015 DA - 2015// TI - ACK1/TNK2 tyrosine kinase: molecular signaling and evolving role in cancers JO - Oncogene VL - 34 UR - https://doi.org/10.1038/onc.2014.350 DO - 10.1038/onc.2014.350 ID - Mahajan2015 ER - TY - JOUR AU - Mahajan, K. AU - Mahajan, N. P. PY - 2010 DA - 2010// TI - Shepherding AKT and androgen receptor by Ack1 tyrosine kinase JO - J Cell Physiol VL - 224 UR - https://doi.org/10.1002/jcp.22162 DO - 10.1002/jcp.22162 ID - Mahajan2010 ER - TY - JOUR AU - Grovdal, L. M. AU - Johannessen, L. E. AU - Rodland, M. S. AU - Madshus, I. H. AU - Stang, E. PY - 2008 DA - 2008// TI - Dysregulation of Ack1 inhibits down-regulation of the EGF receptor JO - Exp Cell Res VL - 314 UR - https://doi.org/10.1016/j.yexcr.2007.12.017 DO - 10.1016/j.yexcr.2007.12.017 ID - Grovdal2008 ER - TY - JOUR AU - Mahajan, K. AU - Coppola, D. AU - Challa, S. AU - Fang, B. AU - Chen, Y. A. AU - Zhu, W. AU - Lopez, A. S. AU - Koomen, J. AU - Engelman, R. W. AU - Rivera, C. PY - 2010 DA - 2010// TI - Ack1 mediated AKT/PKB tyrosine 176 phosphorylation regulates its activation JO - PLoS One VL - 5 UR - https://doi.org/10.1371/journal.pone.0009646 DO - 10.1371/journal.pone.0009646 ID - Mahajan2010 ER - TY - JOUR AU - Mahajan, N. P. AU - Whang, Y. E. AU - Mohler, J. L. AU - Earp, H. S. PY - 2005 DA - 2005// TI - Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor Wwox JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-05-1127 DO - 10.1158/0008-5472.CAN-05-1127 ID - Mahajan2005 ER - TY - JOUR AU - Xie, B. AU - Zen, Q. AU - Wang, X. AU - He, X. AU - Xie, Y. AU - Zhang, Z. AU - Li, H. PY - 2015 DA - 2015// TI - ACK1 promotes hepatocellular carcinoma progression via downregulating WWOX and activating AKT signaling JO - Int J Oncol VL - 46 UR - https://doi.org/10.3892/ijo.2015.2910 DO - 10.3892/ijo.2015.2910 ID - Xie2015 ER - TY - STD TI - Xu SH, Huang JZ, Chen M, Zeng M, Zou FY, Chen, Yan GR: Amplification of ACK1 promotes gastric tumorigenesis via ECD-dependent p53 ubiquitination degradation. Oncotarget 2017, 8:12705–12716. ID - ref87 ER - TY - JOUR AU - Mahajan, K. AU - Mahajan, N. P. PY - 2013 DA - 2013// TI - ACK1 tyrosine kinase: targeted inhibition to block cancer cell proliferation JO - Cancer Lett VL - 338 UR - https://doi.org/10.1016/j.canlet.2013.04.004 DO - 10.1016/j.canlet.2013.04.004 ID - Mahajan2013 ER - TY - JOUR AU - Liu, Z. AU - Liu, Z. AU - Zhang, Y. AU - Li, Y. AU - Liu, B. AU - Zhang, K. PY - 2017 DA - 2017// TI - miR-24 represses metastasis of human osteosarcoma cells by targeting Ack1 via AKT/MMPs pathway JO - Biochem Biophys Res Commun VL - 486 UR - https://doi.org/10.1016/j.bbrc.2017.02.045 DO - 10.1016/j.bbrc.2017.02.045 ID - Liu2017 ER - TY - JOUR AU - Lv, C. AU - Zhao, X. AU - Gu, H. AU - Huang, L. AU - Zhou, S. AU - Zhi, F. PY - 2016 DA - 2016// TI - Involvement of Activated Cdc42 Kinase1 in Colitis and Colorectal Neoplasms JO - Med Sci Monit VL - 22 UR - https://doi.org/10.12659/MSM.902274 DO - 10.12659/MSM.902274 ID - Lv2016 ER - TY - JOUR AU - Xu, S. H. AU - Huang, J. Z. AU - Xu, M. L. AU - Yu, G. AU - Yin, X. F. AU - Chen, D. AU - Yan, G. R. PY - 2015 DA - 2015// TI - ACK1 promotes gastric cancer epithelial-mesenchymal transition and metastasis through AKT-POU2F1-ECD signalling JO - J Pathol VL - 236 UR - https://doi.org/10.1002/path.4515 DO - 10.1002/path.4515 ID - Xu2015 ER - TY - JOUR AU - Maxson, J. E. AU - Abel, M. L. AU - Wang, J. AU - Deng, X. AU - Reckel, S. AU - Luty, S. B. AU - Sun, H. AU - Gorenstein, J. AU - Hughes, S. B. AU - Bottomly, D. PY - 2016 DA - 2016// TI - Identification and Characterization of Tyrosine Kinase Nonreceptor 2 Mutations in Leukemia through Integration of Kinase Inhibitor Screening and Genomic Analysis JO - Cancer Res VL - 76 UR - https://doi.org/10.1158/0008-5472.CAN-15-0817 DO - 10.1158/0008-5472.CAN-15-0817 ID - Maxson2016 ER - TY - JOUR AU - Nonami, A. AU - Sattler, M. AU - Weisberg, E. AU - Liu, Q. AU - Zhang, J. AU - Patricelli, M. P. AU - Christie, A. L. AU - Saur, A. M. AU - Kohl, N. E. AU - Kung, A. L. PY - 2015 DA - 2015// TI - Identification of novel therapeutic targets in acute leukemias with NRAS mutations using a pharmacologic approach JO - Blood VL - 125 UR - https://doi.org/10.1182/blood-2014-12-615906 DO - 10.1182/blood-2014-12-615906 ID - Nonami2015 ER - TY - JOUR AU - Hoehn, G. T. AU - Stokland, T. AU - Amin, S. AU - Ramirez, M. AU - Hawkins, A. L. AU - Griffin, C. A. AU - Small, D. AU - Civin, C. I. PY - 1996 DA - 1996// TI - Tnk1: a novel intracellular tyrosine kinase gene isolated from human umbilical cord blood CD34+/Lin-/CD38- stem/progenitor cells JO - Oncogene VL - 12 ID - Hoehn1996 ER - TY - JOUR AU - Hoare, K. AU - Hoare, S. AU - Smith, O. M. AU - Kalmaz, G. AU - Small, D. AU - Stratford May, W. PY - 2003 DA - 2003// TI - Kos1, a nonreceptor tyrosine kinase that suppresses Ras signaling JO - Oncogene VL - 22 UR - https://doi.org/10.1038/sj.onc.1206480 DO - 10.1038/sj.onc.1206480 ID - Hoare2003 ER - TY - JOUR AU - Azoitei, N. AU - Brey, A. AU - Busch, T. AU - Fulda, S. AU - Adler, G. AU - Seufferlein, T. PY - 2007 DA - 2007// TI - Thirty-eight-negative kinase 1 (TNK1) facilitates TNFalpha-induced apoptosis by blocking NF-kappaB activation JO - Oncogene VL - 26 UR - https://doi.org/10.1038/sj.onc.1210476 DO - 10.1038/sj.onc.1210476 ID - Azoitei2007 ER - TY - JOUR AU - Henderson, M. C. AU - Gonzales, I. M. AU - Arora, S. AU - Choudhary, A. AU - Trent, J. M. AU - Von Hoff, D. D. AU - Mousses, S. AU - Azorsa, D. O. PY - 2011 DA - 2011// TI - High-throughput RNAi screening identifies a role for TNK1 in growth and survival of pancreatic cancer cells JO - Mol Cancer Res VL - 9 UR - https://doi.org/10.1158/1541-7786.MCR-10-0436 DO - 10.1158/1541-7786.MCR-10-0436 ID - Henderson2011 ER - TY - JOUR AU - Cho, N. L. AU - Lin, C. I. AU - Du, J. AU - Whang, E. E. AU - Ito, H. AU - Moore, F. D. AU - Ruan, D. T. PY - 2012 DA - 2012// TI - Global tyrosine kinome profiling of human thyroid tumors identifies Src as a promising target for invasive cancers JO - Biochem Biophys Res Commun VL - 421 UR - https://doi.org/10.1016/j.bbrc.2012.04.034 DO - 10.1016/j.bbrc.2012.04.034 ID - Cho2012 ER - TY - JOUR AU - Kobayashi, T. AU - Nakamura, S. AU - Taniguchi, T. AU - Yamamura, H. PY - 1990 DA - 1990// TI - Purification and characterization of a cytosolic protein-tyrosine kinase from porcine spleen JO - Eur J Biochem VL - 188 UR - https://doi.org/10.1111/j.1432-1033.1990.tb15433.x DO - 10.1111/j.1432-1033.1990.tb15433.x ID - Kobayashi1990 ER - TY - JOUR AU - Taniguchi, T. AU - Kobayashi, T. AU - Kondo, J. AU - Takahashi, K. AU - Nakamura, H. AU - Suzuki, J. AU - Nagai, K. AU - Yamada, T. AU - Nakamura, S. AU - Yamamura, H. PY - 1991 DA - 1991// TI - Molecular cloning of a porcine gene syk that encodes a 72-kDa protein-tyrosine kinase showing high susceptibility to proteolysis JO - J Biol Chem VL - 266 ID - Taniguchi1991 ER - TY - JOUR AU - Wu, C. AU - Orozco, C. AU - Boyer, J. AU - Leglise, M. AU - Goodale, J. AU - Batalov, S. AU - Hodge, C. L. AU - Haase, J. AU - Janes, J. AU - Huss, J. W. AU - Su, A. I. PY - 2009 DA - 2009// TI - BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources JO - Genome Biol VL - 10 UR - https://doi.org/10.1186/gb-2009-10-11-r130 DO - 10.1186/gb-2009-10-11-r130 ID - Wu2009 ER - TY - JOUR AU - Shin, G. AU - Kang, T. W. AU - Yang, S. AU - Baek, S. J. AU - Jeong, Y. S. AU - Kim, S. Y. PY - 2011 DA - 2011// TI - GENT: gene expression database of normal and tumor tissues JO - Cancer Inform VL - 10 UR - https://doi.org/10.4137/CIN.S7226 DO - 10.4137/CIN.S7226 ID - Shin2011 ER - TY - JOUR AU - Feng, G. AU - Wang, X. PY - 2014 DA - 2014// TI - Role of spleen tyrosine kinase in the pathogenesis of chronic lymphocytic leukemia JO - Leuk Lymphoma VL - 55 UR - https://doi.org/10.3109/10428194.2014.891026 DO - 10.3109/10428194.2014.891026 ID - Feng2014 ER - TY - JOUR AU - Liu, D. AU - Mamorska-Dyga, A. PY - 2017 DA - 2017// TI - Syk inhibitors in clinical development for hematological malignancies JO - J Hematol Oncol VL - 10 UR - https://doi.org/10.1186/s13045-017-0512-1 DO - 10.1186/s13045-017-0512-1 ID - Liu2017 ER - TY - JOUR AU - Efremov, D. G. AU - Laurenti, L. PY - 2011 DA - 2011// TI - The Syk kinase as a therapeutic target in leukemia and lymphoma JO - Expert Opin Investig Drugs VL - 20 UR - https://doi.org/10.1517/13543784.2011.570329 DO - 10.1517/13543784.2011.570329 ID - Efremov2011 ER - TY - JOUR AU - Krisenko, M. O. AU - Geahlen, R. L. PY - 1853 DA - 1853// TI - Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer JO - Biochim Biophys Acta VL - 2015 ID - Krisenko1853 ER - TY - JOUR AU - Qiu, L. AU - Wang, F. AU - Liu, S. AU - Chen, X. L. PY - 2014 DA - 2014// TI - Current understanding of tyrosine kinase BMX in inflammation and its inhibitors JO - Burns Trauma VL - 2 UR - https://doi.org/10.4103/2321-3868.135483 DO - 10.4103/2321-3868.135483 ID - Qiu2014 ER - TY - JOUR AU - Mohamed, A. J. AU - Yu, L. AU - Backesjo, C. M. AU - Vargas, L. AU - Faryal, R. AU - Aints, A. AU - Christensson, B. AU - Berglof, A. AU - Vihinen, M. AU - Nore, B. F. AU - Smith, C. I. PY - 2009 DA - 2009// TI - Bruton's tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain JO - Immunol Rev VL - 228 UR - https://doi.org/10.1111/j.1600-065X.2008.00741.x DO - 10.1111/j.1600-065X.2008.00741.x ID - Mohamed2009 ER - TY - JOUR AU - Akinleye, A. AU - Furqan, M. AU - Adekunle, O. PY - 2014 DA - 2014// TI - Ibrutinib and indolent B-cell lymphomas JO - Clin Lymphoma Myeloma Leuk VL - 14 UR - https://doi.org/10.1016/j.clml.2013.11.005 DO - 10.1016/j.clml.2013.11.005 ID - Akinleye2014 ER - TY - JOUR AU - Tojo, A. PY - 2014 DA - 2014// TI - Kinase inhibitors against hematological malignancies JO - Nihon Rinsho VL - 72 ID - Tojo2014 ER - TY - STD TI - Molina-Cerrillo J, Alonso-Gordoa T, Gajate P, Grande E. Brutońs tyrosine kinase (BTK) as a promising target in solid tumors. Cancer Treat Rev. 2017;58:41–50. ID - ref111 ER - TY - JOUR AU - Zhong, Y. AU - Dong, S. AU - Strattan, E. AU - Ren, L. AU - Butchar, J. P. AU - Thornton, K. AU - Mishra, A. AU - Porcu, P. AU - Bradshaw, J. M. AU - Bisconte, A. PY - 2015 DA - 2015// TI - Targeting interleukin-2-inducible T-cell kinase (ITK) and resting lymphocyte kinase (RLK) using a novel covalent inhibitor PRN694 JO - J Biol Chem VL - 290 UR - https://doi.org/10.1074/jbc.M114.614891 DO - 10.1074/jbc.M114.614891 ID - Zhong2015 ER - TY - JOUR AU - Xu, W. D. AU - Su, L. C. AU - Xie, Q. B. AU - Zhao, Y. AU - Liu, Y. PY - 2016 DA - 2016// TI - Interleukin-2-inducible T-cell kinase expression and relation to disease severity in systemic lupus erythematosus JO - Clin Chim Acta VL - 463 UR - https://doi.org/10.1016/j.cca.2016.10.010 DO - 10.1016/j.cca.2016.10.010 ID - Xu2016 ER - TY - JOUR AU - Felices, M. AU - Berg, L. J. PY - 2008 DA - 2008// TI - The Tec kinases Itk and Rlk regulate NKT cell maturation, cytokine production, and survival JO - J Immunol VL - 180 UR - https://doi.org/10.4049/jimmunol.180.5.3007 DO - 10.4049/jimmunol.180.5.3007 ID - Felices2008 ER - TY - JOUR AU - Berg, L. J. AU - Finkelstein, L. D. AU - Lucas, J. A. AU - Schwartzberg, P. L. PY - 2005 DA - 2005// TI - Tec family kinases in T lymphocyte development and function JO - Annu Rev Immunol VL - 23 UR - https://doi.org/10.1146/annurev.immunol.22.012703.104743 DO - 10.1146/annurev.immunol.22.012703.104743 ID - Berg2005 ER - TY - JOUR AU - Finkelstein, L. D. AU - Shimizu, Y. AU - Schwartzberg, P. L. PY - 2005 DA - 2005// TI - Tec kinases regulate TCR-mediated recruitment of signaling molecules and integrin-dependent cell adhesion JO - J Immunol VL - 175 UR - https://doi.org/10.4049/jimmunol.175.9.5923 DO - 10.4049/jimmunol.175.9.5923 ID - Finkelstein2005 ER - TY - JOUR AU - Readinger, J. A. AU - Mueller, K. L. AU - Venegas, A. M. AU - Horai, R. AU - Schwartzberg, P. L. PY - 2009 DA - 2009// TI - Tec kinases regulate T-lymphocyte development and function: new insights into the roles of Itk and Rlk/Txk JO - Immunol Rev VL - 228 UR - https://doi.org/10.1111/j.1600-065X.2008.00757.x DO - 10.1111/j.1600-065X.2008.00757.x ID - Readinger2009 ER - TY - JOUR AU - Takeba, Y. AU - Nagafuchi, H. AU - Takeno, M. AU - Kashiwakura, J. AU - Suzuki, N. PY - 2002 DA - 2002// TI - Txk, a member of nonreceptor tyrosine kinase of Tec family, acts as a Th1 cell-specific transcription factor and regulates IFN-gamma gene transcription JO - J Immunol VL - 168 UR - https://doi.org/10.4049/jimmunol.168.5.2365 DO - 10.4049/jimmunol.168.5.2365 ID - Takeba2002 ER - TY - JOUR AU - Mosmann, T. R. AU - Coffman, R. L. PY - 1989 DA - 1989// TI - TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties JO - Annu Rev Immunol VL - 7 UR - https://doi.org/10.1146/annurev.iy.07.040189.001045 DO - 10.1146/annurev.iy.07.040189.001045 ID - Mosmann1989 ER - TY - JOUR AU - Seder, R. A. AU - Paul, W. E. PY - 1994 DA - 1994// TI - Acquisition of lymphokine-producing phenotype by CD4+ T cells JO - Annu Rev Immunol VL - 12 UR - https://doi.org/10.1146/annurev.iy.12.040194.003223 DO - 10.1146/annurev.iy.12.040194.003223 ID - Seder1994 ER - TY - JOUR AU - Gately, M. K. AU - Renzetti, L. M. AU - Magram, J. AU - Stern, A. S. AU - Adorini, L. AU - Gubler, U. AU - Presky, D. H. PY - 1998 DA - 1998// TI - The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses JO - Annu Rev Immunol VL - 16 UR - https://doi.org/10.1146/annurev.immunol.16.1.495 DO - 10.1146/annurev.immunol.16.1.495 ID - Gately1998 ER - TY - JOUR AU - Abbas, A. K. AU - Murphy, K. M. AU - Sher, A. PY - 1996 DA - 1996// TI - Functional diversity of helper T lymphocytes JO - Nature VL - 383 UR - https://doi.org/10.1038/383787a0 DO - 10.1038/383787a0 ID - Abbas1996 ER - TY - JOUR AU - Block, H. AU - Zarbock, A. PY - 2012 DA - 2012// TI - The role of the tec kinase Bruton's tyrosine kinase (Btk) in leukocyte recruitment JO - Int Rev Immunol VL - 31 UR - https://doi.org/10.3109/08830185.2012.668982 DO - 10.3109/08830185.2012.668982 ID - Block2012 ER - TY - JOUR AU - Gottar-Guillier, M. AU - Dodeller, F. AU - Huesken, D. AU - Iourgenko, V. AU - Mickanin, C. AU - Labow, M. AU - Gaveriaux, S. AU - Kinzel, B. AU - Mueller, M. AU - Alitalo, K. PY - 2011 DA - 2011// TI - The tyrosine kinase BMX is an essential mediator of inflammatory arthritis in a kinase-independent manner JO - J Immunol VL - 186 UR - https://doi.org/10.4049/jimmunol.1002813 DO - 10.4049/jimmunol.1002813 ID - Gottar-Guillier2011 ER - TY - JOUR AU - Yu, L. AU - Simonson, O. E. AU - Mohamed, A. J. AU - Smith, C. I. PY - 2009 DA - 2009// TI - NF-kappaB regulates the transcription of protein tyrosine kinase Tec JO - FEBS J VL - 276 UR - https://doi.org/10.1111/j.1742-4658.2009.07385.x DO - 10.1111/j.1742-4658.2009.07385.x ID - Yu2009 ER - TY - JOUR AU - Mano, H. AU - Ishikawa, F. AU - Nishida, J. AU - Hirai, H. AU - Takaku, F. PY - 1990 DA - 1990// TI - A novel protein-tyrosine kinase, tec, is preferentially expressed in liver JO - Oncogene VL - 5 ID - Mano1990 ER - TY - JOUR AU - Chen, C. AU - Wang, G. AU - Zhang, Z. M. AU - Xu, W. AU - Li, Q. AU - Hu, Q. AU - Wang, D. AU - Li, Z. P. AU - Yang, Z. X. AU - Suo, J. Y. PY - 2007 DA - 2007// TI - The expression of Tec and the level of its phosphorylation in primary hepatic carcinomas JO - Zhonghua Gan Zang Bing Za Zhi VL - 15 ID - Chen2007 ER - TY - JOUR AU - Vanova, T. AU - Konecna, Z. AU - Zbonakova, Z. AU - La Venuta, G. AU - Zoufalova, K. AU - Jelinkova, S. AU - Varecha, M. AU - Rotrekl, V. AU - Krejci, P. AU - Nickel, W. PY - 2017 DA - 2017// TI - Tyrosine Kinase Expressed in Hepatocellular Carcinoma, TEC, Controls Pluripotency and Early Cell Fate Decisions of Human Pluripotent Stem Cells via Regulation of Fibroblast Growth Factor-2 Secretion JO - Stem Cells VL - 35 UR - https://doi.org/10.1002/stem.2660 DO - 10.1002/stem.2660 ID - Vanova2017 ER - TY - JOUR AU - Ozkal, S. AU - Paterson, J. C. AU - Tedoldi, S. AU - Hansmann, M. L. AU - Kargi, A. AU - Manek, S. AU - Mason, D. Y. AU - Marafioti, T. PY - 2009 DA - 2009// TI - Focal adhesion kinase (FAK) expression in normal and neoplastic lymphoid tissues JO - Pathol Res Pract VL - 205 UR - https://doi.org/10.1016/j.prp.2009.07.002 DO - 10.1016/j.prp.2009.07.002 ID - Ozkal2009 ER - TY - JOUR AU - Bryant, P. W. AU - Zheng, Q. AU - Pumiglia, K. M. PY - 2012 DA - 2012// TI - Focal adhesion kinase is a phospho-regulated repressor of Rac and proliferation in human endothelial cells JO - Biology open VL - 1 UR - https://doi.org/10.1242/bio.20121008 DO - 10.1242/bio.20121008 ID - Bryant2012 ER - TY - JOUR AU - Carter, B. Z. AU - Mak, P. Y. AU - Wang, X. AU - Yang, H. AU - Garcia-Manero, G. AU - Mak, D. H. AU - Mu, H. AU - Ruvolo, V. R. AU - Qiu, Y. AU - Coombes, K. PY - 2017 DA - 2017// TI - Focal Adhesion Kinase as a Potential Target in AML and MDS JO - Mol Cancer Ther VL - 16 UR - https://doi.org/10.1158/1535-7163.MCT-16-0719 DO - 10.1158/1535-7163.MCT-16-0719 ID - Carter2017 ER - TY - JOUR AU - Recher, C. AU - Ysebaert, L. AU - Beyne-Rauzy, O. AU - Mansat-De Mas, V. AU - Ruidavets, J. B. AU - Cariven, P. AU - Demur, C. AU - Payrastre, B. AU - Laurent, G. AU - Racaud-Sultan, C. PY - 2004 DA - 2004// TI - Expression of focal adhesion kinase in acute myeloid leukemia is associated with enhanced blast migration, increased cellularity, and poor prognosis JO - Cancer Res VL - 64 UR - https://doi.org/10.1158/0008-5472.CAN-03-3005 DO - 10.1158/0008-5472.CAN-03-3005 ID - Recher2004 ER - TY - JOUR AU - Aly, R. M. AU - Ghazy, H. F. PY - 2014 DA - 2014// TI - High expression of GTPase regulator associated with the focal adhesion kinase (GRAF) is a favorable prognostic factor in acute myeloid leukemia JO - Blood Cells Mol Dis VL - 53 UR - https://doi.org/10.1016/j.bcmd.2014.07.004 DO - 10.1016/j.bcmd.2014.07.004 ID - Aly2014 ER - TY - JOUR AU - Parsons, S. J. AU - Parsons, J. T. PY - 2004 DA - 2004// TI - Src family kinases, key regulators of signal transduction JO - Oncogene VL - 23 UR - https://doi.org/10.1038/sj.onc.1208160 DO - 10.1038/sj.onc.1208160 ID - Parsons2004 ER - TY - JOUR AU - Sen, B. AU - Johnson, F. M. PY - 2011 DA - 2011// TI - Regulation of SRC family kinases in human cancers JO - J Signal Transduct VL - 2011 UR - https://doi.org/10.1155/2011/865819 DO - 10.1155/2011/865819 ID - Sen2011 ER - TY - JOUR AU - Boggon, T. J. AU - Eck, M. J. PY - 2004 DA - 2004// TI - Structure and regulation of Src family kinases JO - Oncogene VL - 23 UR - https://doi.org/10.1038/sj.onc.1208081 DO - 10.1038/sj.onc.1208081 ID - Boggon2004 ER - TY - JOUR AU - Summy, J. M. AU - Gallick, G. E. PY - 2003 DA - 2003// TI - Src family kinases in tumor progression and metastasis JO - Cancer Metastasis Rev VL - 22 UR - https://doi.org/10.1023/A:1023772912750 DO - 10.1023/A:1023772912750 ID - Summy2003 ER - TY - JOUR AU - Bromann, P. A. AU - Korkaya, H. AU - Courtneidge, S. A. PY - 2004 DA - 2004// TI - The interplay between Src family kinases and receptor tyrosine kinases JO - Oncogene VL - 23 UR - https://doi.org/10.1038/sj.onc.1208079 DO - 10.1038/sj.onc.1208079 ID - Bromann2004 ER - TY - JOUR AU - Luttrell, D. K. AU - Luttrell, L. M. PY - 2004 DA - 2004// TI - Not so strange bedfellows: G-protein-coupled receptors and Src family kinases JO - Oncogene VL - 23 UR - https://doi.org/10.1038/sj.onc.1208162 DO - 10.1038/sj.onc.1208162 ID - Luttrell2004 ER - TY - JOUR AU - Xu, W. AU - Harrison, S. C. AU - Eck, M. J. PY - 1997 DA - 1997// TI - Three-dimensional structure of the tyrosine kinase c-Src JO - Nature VL - 385 UR - https://doi.org/10.1038/385595a0 DO - 10.1038/385595a0 ID - Xu1997 ER - TY - JOUR AU - Reynolds, A. B. AU - Roczniak-Ferguson, A. PY - 2004 DA - 2004// TI - Emerging roles for p120-catenin in cell adhesion and cancer JO - Oncogene VL - 23 UR - https://doi.org/10.1038/sj.onc.1208161 DO - 10.1038/sj.onc.1208161 ID - Reynolds2004 ER - TY - JOUR AU - Silva, C. M. PY - 2004 DA - 2004// TI - Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis JO - Oncogene VL - 23 UR - https://doi.org/10.1038/sj.onc.1208159 DO - 10.1038/sj.onc.1208159 ID - Silva2004 ER - TY - JOUR AU - Playford, M. P. AU - Schaller, M. D. PY - 2004 DA - 2004// TI - The interplay between Src and integrins in normal and tumor biology JO - Oncogene VL - 23 UR - https://doi.org/10.1038/sj.onc.1208080 DO - 10.1038/sj.onc.1208080 ID - Playford2004 ER - TY - JOUR AU - Bourrie, B. AU - Brassard, D. L. AU - Cosnier-Pucheu, S. AU - Zilberstein, A. AU - Yu, K. AU - Levit, M. AU - Morrison, J. G. AU - Perreaut, P. AU - Jegham, S. AU - Hilairet, S. PY - 2013 DA - 2013// TI - SAR103168: a tyrosine kinase inhibitor with therapeutic potential in myeloid leukemias JO - Leuk Lymphoma VL - 54 UR - https://doi.org/10.3109/10428194.2012.745071 DO - 10.3109/10428194.2012.745071 ID - Bourrie2013 ER - TY - JOUR AU - Bunda, S. AU - Kang, M. W. AU - Sybingco, S. S. AU - Weng, J. AU - Favre, H. AU - Shin, D. H. AU - Irwin, M. S. AU - Loh, M. L. AU - Ohh, M. PY - 2013 DA - 2013// TI - Inhibition of SRC corrects GM-CSF hypersensitivity that underlies juvenile myelomonocytic leukemia JO - Cancer Res VL - 73 UR - https://doi.org/10.1158/0008-5472.CAN-12-3425 DO - 10.1158/0008-5472.CAN-12-3425 ID - Bunda2013 ER - TY - JOUR AU - Miranda, M. B. AU - Johnson, D. E. PY - 2007 DA - 2007// TI - Signal transduction pathways that contribute to myeloid differentiation JO - Leukemia VL - 21 UR - https://doi.org/10.1038/sj.leu.2404690 DO - 10.1038/sj.leu.2404690 ID - Miranda2007 ER - TY - JOUR AU - Palacios, E. H. AU - Weiss, A. PY - 2004 DA - 2004// TI - Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation JO - Oncogene VL - 23 UR - https://doi.org/10.1038/sj.onc.1208074 DO - 10.1038/sj.onc.1208074 ID - Palacios2004 ER - TY - JOUR AU - Gauld, S. B. AU - Cambier, J. C. PY - 2004 DA - 2004// TI - Src-family kinases in B-cell development and signaling JO - Oncogene VL - 23 UR - https://doi.org/10.1038/sj.onc.1208075 DO - 10.1038/sj.onc.1208075 ID - Gauld2004 ER - TY - JOUR AU - Warmuth, M. AU - Damoiseaux, R. AU - Liu, Y. AU - Fabbro, D. AU - Gray, N. PY - 2003 DA - 2003// TI - SRC family kinases: potential targets for the treatment of human cancer and leukemia JO - Curr Pharm Des VL - 9 UR - https://doi.org/10.2174/1381612033454126 DO - 10.2174/1381612033454126 ID - Warmuth2003 ER - TY - JOUR AU - Ku, M. AU - Wall, M. AU - MacKinnon, R. N. AU - Walkley, C. R. AU - Purton, L. E. AU - Tam, C. AU - Izon, D. AU - Campbell, L. AU - Cheng, H. C. AU - Nandurkar, H. PY - 2015 DA - 2015// TI - Src family kinases and their role in hematological malignancies JO - Leuk Lymphoma VL - 56 UR - https://doi.org/10.3109/10428194.2014.907897 DO - 10.3109/10428194.2014.907897 ID - Ku2015 ER - TY - JOUR AU - Okada, M. PY - 2012 DA - 2012// TI - Regulation of the SRC family kinases by Csk JO - Int J Biol Sci VL - 8 UR - https://doi.org/10.7150/ijbs.5141 DO - 10.7150/ijbs.5141 ID - Okada2012 ER - TY - JOUR AU - Chan, P. C. AU - Chen, H. C. PY - 2012 DA - 2012// TI - p120RasGAP-mediated activation of c-Src is critical for oncogenic Ras to induce tumor invasion JO - Cancer Res VL - 72 UR - https://doi.org/10.1158/0008-5472.CAN-11-3078 DO - 10.1158/0008-5472.CAN-11-3078 ID - Chan2012 ER - TY - JOUR AU - Congleton, J. AU - MacDonald, R. AU - Yen, A. PY - 2012 DA - 2012// TI - Src inhibitors, PP2 and dasatinib, increase retinoic acid-induced association of Lyn and c-Raf (S259) and enhance MAPK-dependent differentiation of myeloid leukemia cells JO - Leukemia VL - 26 UR - https://doi.org/10.1038/leu.2011.390 DO - 10.1038/leu.2011.390 ID - Congleton2012 ER - TY - JOUR AU - Zhang, S. AU - Yu, D. PY - 2012 DA - 2012// TI - Targeting Src family kinases in anti-cancer therapies: turning promise into triumph JO - Trends Pharmacol Sci VL - 33 UR - https://doi.org/10.1016/j.tips.2011.11.002 DO - 10.1016/j.tips.2011.11.002 ID - Zhang2012 ER - TY - JOUR AU - Mayer, E. L. AU - Krop, I. E. PY - 2010 DA - 2010// TI - Advances in targeting SRC in the treatment of breast cancer and other solid malignancies JO - Clin Cancer Res VL - 16 UR - https://doi.org/10.1158/1078-0432.CCR-09-1834 DO - 10.1158/1078-0432.CCR-09-1834 ID - Mayer2010 ER - TY - JOUR AU - Donato, N. J. AU - Wu, J. Y. AU - Stapley, J. AU - Gallick, G. AU - Lin, H. AU - Arlinghaus, R. AU - Talpaz, M. PY - 2003 DA - 2003// TI - BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571 JO - Blood VL - 101 UR - https://doi.org/10.1182/blood.V101.2.690 DO - 10.1182/blood.V101.2.690 ID - Donato2003 ER - TY - JOUR AU - Pene-Dumitrescu, T. AU - Smithgall, T. E. PY - 2010 DA - 2010// TI - Expression of a Src family kinase in chronic myelogenous leukemia cells induces resistance to imatinib in a kinase-dependent manner JO - J Biol Chem VL - 285 UR - https://doi.org/10.1074/jbc.M109.090043 DO - 10.1074/jbc.M109.090043 ID - Pene-Dumitrescu2010 ER - TY - JOUR AU - Malek, R. L. AU - Irby, R. B. AU - Guo, Q. M. AU - Lee, K. AU - Wong, S. AU - He, M. AU - Tsai, J. AU - Bryan, F. AU - Liu, E. T. AU - Quackenbush, J. PY - 2002 DA - 2002// TI - Identification of Src transformation fingerprint in human colon cancer JO - Oncogene VL - 21 UR - https://doi.org/10.1038/sj.onc.1205900 DO - 10.1038/sj.onc.1205900 ID - Malek2002 ER - TY - JOUR AU - Kato, J. AU - Takeya, T. AU - Grandori, C. AU - Iba, H. AU - Levy, J. AU - Hanafusa, H. PY - 1986 DA - 1986// TI - Amino acid substitutions sufficient to convert the nontransforming p60c-src protein to a transforming protein JO - Mol Cell Biol VL - 6 UR - https://doi.org/10.1128/MCB.6.12.4155 DO - 10.1128/MCB.6.12.4155 ID - Kato1986 ER - TY - JOUR AU - Levy, J. B. AU - Iba, H. AU - Hanafusa, H. PY - 1986 DA - 1986// TI - Activation of the transforming potential of p60c-src by a single amino acid change JO - Proc Natl Acad Sci VL - 83 UR - https://doi.org/10.1073/pnas.83.12.4228 DO - 10.1073/pnas.83.12.4228 ID - Levy1986 ER - TY - JOUR AU - Saito, Y. D. AU - Jensen, A. R. AU - Salgia, R. AU - Posadas, E. M. PY - 2010 DA - 2010// TI - Fyn: a novel molecular target in cancer JO - Cancer VL - 116 UR - https://doi.org/10.1002/cncr.24879 DO - 10.1002/cncr.24879 ID - Saito2010 ER - TY - JOUR AU - Singh, M. M. AU - Howard, A. AU - Irwin, M. E. AU - Gao, Y. AU - Lu, X. AU - Multani, A. AU - Chandra, J. PY - 2012 DA - 2012// TI - Expression and activity of Fyn mediate proliferation and blastic features of chronic myelogenous leukemia JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0051611 DO - 10.1371/journal.pone.0051611 ID - Singh2012 ER - TY - JOUR AU - Gao, Y. AU - Howard, A. AU - Ban, K. AU - Chandra, J. PY - 2009 DA - 2009// TI - Oxidative stress promotes transcriptional up-regulation of Fyn in BCR-ABL1-expressing cells JO - J Biol Chem VL - 284 UR - https://doi.org/10.1074/jbc.M804801200 DO - 10.1074/jbc.M804801200 ID - Gao2009 ER - TY - JOUR AU - Contri, A. AU - Brunati, A. M. AU - Trentin, L. AU - Cabrelle, A. AU - Miorin, M. AU - Cesaro, L. AU - Pinna, L. A. AU - Zambello, R. AU - Semenzato, G. AU - Donella-Deana, A. PY - 2005 DA - 2005// TI - Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis JO - J Clin Invest VL - 115 UR - https://doi.org/10.1172/JCI200522094 DO - 10.1172/JCI200522094 ID - Contri2005 ER - TY - JOUR AU - Hussein, K. AU - von Neuhoff, N. AU - Busche, G. AU - Buhr, T. AU - Kreipe, H. AU - Bock, O. PY - 2009 DA - 2009// TI - Opposite expression pattern of Src kinase Lyn in acute and chronic haematological malignancies JO - Ann Hematol VL - 88 UR - https://doi.org/10.1007/s00277-009-0727-5 DO - 10.1007/s00277-009-0727-5 ID - Hussein2009 ER - TY - JOUR AU - Tibaldi, E. AU - Pagano, M. A. AU - Frezzato, F. AU - Trimarco, V. AU - Facco, M. AU - Zagotto, G. AU - Ribaudo, G. AU - Pavan, V. AU - Bordin, L. AU - Visentin, A. PY - 2017 DA - 2017// TI - Targeted activation of the SHP-1/PP2A signaling axis elicits apoptosis of chronic lymphocytic leukemia cells JO - Haematologica VL - 102 UR - https://doi.org/10.3324/haematol.2016.155747 DO - 10.3324/haematol.2016.155747 ID - Tibaldi2017 ER - TY - JOUR AU - Gattazzo, C. AU - Martini, V. AU - Frezzato, F. AU - Trimarco, V. AU - Tibaldi, E. AU - Castelli, M. AU - Facco, M. AU - Zonta, F. AU - Brunati, A. M. AU - Zambello, R. PY - 2014 DA - 2014// TI - Cortactin, another player in the Lyn signaling pathway, is over-expressed and alternatively spliced in leukemic cells from patients with B-cell chronic lymphocytic leukemia JO - Haematologica VL - 99 UR - https://doi.org/10.3324/haematol.2013.090183 DO - 10.3324/haematol.2013.090183 ID - Gattazzo2014 ER - TY - JOUR AU - ten Hacken, E. AU - Burger, J. A. PY - 2014 DA - 2014// TI - Molecular pathways: targeting the microenvironment in chronic lymphocytic leukemia--focus on the B-cell receptor JO - Clin Cancer Res VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-13-0226 DO - 10.1158/1078-0432.CCR-13-0226 ID - ten Hacken2014 ER - TY - JOUR AU - Zonta, F. AU - Pagano, M. A. AU - Trentin, L. AU - Tibaldi, E. AU - Frezzato, F. AU - Trimarco, V. AU - Facco, M. AU - Zagotto, G. AU - Pavan, V. AU - Ribaudo, G. PY - 2015 DA - 2015// TI - Lyn sustains oncogenic signaling in chronic lymphocytic leukemia by strengthening SET-mediated inhibition of PP2A JO - Blood VL - 125 UR - https://doi.org/10.1182/blood-2014-12-619155 DO - 10.1182/blood-2014-12-619155 ID - Zonta2015 ER - TY - JOUR AU - Advani, G. AU - Lim, Y. C. AU - Catimel, B. AU - Lio, D. S. S. AU - Ng, N. L. AU - Chüeh, A. C. AU - Tran, M. AU - Anasir, M. I. AU - Verkade, H. AU - Zhu, H. -. J. PY - 2017 DA - 2017// TI - Csk-homologous kinase (Chk) is an efficient inhibitor of Src-family kinases but a poor catalyst of phosphorylation of their C-terminal regulatory tyrosine JO - Cell Communication and Signaling VL - 15 UR - https://doi.org/10.1186/s12964-017-0186-x DO - 10.1186/s12964-017-0186-x ID - Advani2017 ER - TY - JOUR AU - Bodensteiner, D. C. AU - Doolittle, G. C. PY - 1993 DA - 1993// TI - Adverse haematological complications of anticancer drugs. Clinical presentation, management and avoidance JO - Drug Saf VL - 8 UR - https://doi.org/10.2165/00002018-199308030-00003 DO - 10.2165/00002018-199308030-00003 ID - Bodensteiner1993 ER - TY - JOUR AU - Sampi, K. AU - Taguchi, T. PY - 1990 DA - 1990// TI - Gastrointestinal toxicity induced by anticancer drugs--including new antiemetic drugs JO - Gan To Kagaku Ryoho VL - 17 ID - Sampi1990 ER - TY - JOUR AU - Duwe, G. AU - Knitter, S. AU - Pesthy, S. AU - Beierle, A. S. AU - Bahra, M. AU - Schmelzle, M. AU - Schmuck, R. B. AU - Lohneis, P. AU - Raschzok, N. AU - Ollinger, R. PY - 2017 DA - 2017// TI - Hepatotoxicity following systemic therapy for colorectal liver metastases and the impact of chemotherapy-associated liver injury on outcomes after curative liver resection JO - Eur J Surg Oncol VL - 43 UR - https://doi.org/10.1016/j.ejso.2017.05.008 DO - 10.1016/j.ejso.2017.05.008 ID - Duwe2017 ER - TY - JOUR AU - Lameire, N. PY - 2014 DA - 2014// TI - Nephrotoxicity of recent anti-cancer agents JO - Clin Kidney J VL - 7 UR - https://doi.org/10.1093/ckj/sft135 DO - 10.1093/ckj/sft135 ID - Lameire2014 ER - TY - JOUR AU - Arora, A. AU - Scholar, E. M. PY - 2005 DA - 2005// TI - Role of tyrosine kinase inhibitors in cancer therapy JO - J Pharmacol Exp Ther VL - 315 UR - https://doi.org/10.1124/jpet.105.084145 DO - 10.1124/jpet.105.084145 ID - Arora2005 ER - TY - JOUR AU - Illmer, T. AU - Schaich, M. AU - Platzbecker, U. AU - Freiberg-Richter, J. AU - Oelschlagel, U. AU - von Bonin, M. AU - Pursche, S. AU - Bergemann, T. AU - Ehninger, G. AU - Schleyer, E. PY - 2004 DA - 2004// TI - P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate JO - Leukemia VL - 18 UR - https://doi.org/10.1038/sj.leu.2403257 DO - 10.1038/sj.leu.2403257 ID - Illmer2004 ER - TY - JOUR AU - Deenik, W. AU - van der Holt, B. AU - Janssen, J. J. AU - Chu, I. W. AU - Valk, P. J. AU - Ossenkoppele, G. J. AU - van der Heiden, I. P. AU - Sonneveld, P. AU - van Schaik, R. H. AU - Cornelissen, J. J. PY - 2010 DA - 2010// TI - Polymorphisms in the multidrug resistance gene MDR1 (ABCB1) predict for molecular resistance in patients with newly diagnosed chronic myeloid leukemia receiving high-dose imatinib JO - Blood VL - 116 UR - https://doi.org/10.1182/blood-2010-07-296954 DO - 10.1182/blood-2010-07-296954 ID - Deenik2010 ER - TY - JOUR AU - Deremer, D. L. AU - Katsanevas, K. AU - Ustun, C. PY - 2011 DA - 2011// TI - Critical appraisal of nilotinib in frontline treatment of chronic myeloid leukemia JO - Cancer Manag Res VL - 3 UR - https://doi.org/10.2147/CMAR.S11948 DO - 10.2147/CMAR.S11948 ID - Deremer2011 ER - TY - JOUR AU - Bastias, G. AU - Pantoja, T. AU - Leisewitz, T. AU - Zarate, V. PY - 2008 DA - 2008// TI - Health care reform in Chile JO - CMAJ VL - 179 UR - https://doi.org/10.1503/cmaj.071843 DO - 10.1503/cmaj.071843 ID - Bastias2008 ER - TY - JOUR AU - Manley, P. W. AU - Drueckes, P. AU - Fendrich, G. AU - Furet, P. AU - Liebetanz, J. AU - Martiny-Baron, G. AU - Mestan, J. AU - Trappe, J. AU - Wartmann, M. AU - Fabbro, D. PY - 1804 DA - 1804// TI - Extended kinase profile and properties of the protein kinase inhibitor nilotinib JO - Biochim Biophys Acta VL - 2010 ID - Manley1804 ER - TY - JOUR AU - Ray, A. AU - Cowan-Jacob, S. W. AU - Manley, P. W. AU - Mestan, J. AU - Griffin, J. D. PY - 2007 DA - 2007// TI - Identification of BCR-ABL point mutations conferring resistance to the Abl kinase inhibitor AMN107 (nilotinib) by a random mutagenesis study JO - Blood VL - 109 UR - https://doi.org/10.1182/blood-2006-01-015347 DO - 10.1182/blood-2006-01-015347 ID - Ray2007 ER - TY - JOUR AU - Kinch, M. S. AU - Haynesworth, A. AU - Kinch, S. L. AU - Hoyer, D. PY - 2014 DA - 2014// TI - An overview of FDA-approved new molecular entities: 1827-2013 JO - Drug Discov Today VL - 19 UR - https://doi.org/10.1016/j.drudis.2014.03.018 DO - 10.1016/j.drudis.2014.03.018 ID - Kinch2014 ER - TY - JOUR AU - Demain, A. L. PY - 2014 DA - 2014// TI - Importance of microbial natural products and the need to revitalize their discovery JO - J Ind Microbiol Biotechnol VL - 41 UR - https://doi.org/10.1007/s10295-013-1325-z DO - 10.1007/s10295-013-1325-z ID - Demain2014 ER - TY - JOUR AU - Chen, Y. AU - Li, S. PY - 2014 DA - 2014// TI - Omacetaxine mepesuccinate in the treatment of intractable chronic myeloid leukemia JO - Onco Targets Ther VL - 7 ID - Chen2014 ER - TY - JOUR AU - Rosshandler, Y. AU - Shen, A. Q. AU - Cortes, J. AU - Khoury, H. J. PY - 2016 DA - 2016// TI - Omacetaxine Mepesuccinate for Chronic Myeloid Leukemia JO - Expert Rev Hematol VL - 9 UR - https://doi.org/10.1586/17474086.2016.1151351 DO - 10.1586/17474086.2016.1151351 ID - Rosshandler2016 ER - TY - JOUR AU - Chen, Y. AU - Hu, Y. AU - Michaels, S. AU - Segal, D. AU - Brown, D. AU - Li, S. PY - 2009 DA - 2009// TI - Inhibitory effects of omacetaxine on leukemic stem cells and BCR-ABL-induced chronic myeloid leukemia and acute lymphoblastic leukemia in mice JO - Leukemia VL - 23 UR - https://doi.org/10.1038/leu.2009.52 DO - 10.1038/leu.2009.52 ID - Chen2009 ER - TY - JOUR AU - Tong, H. AU - Ren, Y. AU - Zhang, F. AU - Jin, J. PY - 2008 DA - 2008// TI - Homoharringtonine affects the JAK2-STAT5 signal pathway through alteration of protein tyrosine kinase phosphorylation in acute myeloid leukemia cells JO - Eur J Haematol VL - 81 UR - https://doi.org/10.1111/j.1600-0609.2008.01116.x DO - 10.1111/j.1600-0609.2008.01116.x ID - Tong2008 ER - TY - JOUR AU - Coude, M. M. AU - Luycx, O. AU - Cariou, M. E. AU - Maarek, O. AU - Dombret, H. AU - Cayuela, J. M. AU - Rea, D. PY - 2012 DA - 2012// TI - Undetectable molecular residual disease after omacetaxine and nilotinib combination therapy in an imatinib-resistant chronic myeloid leukaemia patient harbouring the BCR-ABL1 T315I gatekeeper mutation JO - Br J Haematol VL - 157 UR - https://doi.org/10.1111/j.1365-2141.2011.09016.x DO - 10.1111/j.1365-2141.2011.09016.x ID - Coude2012 ER - TY - JOUR AU - Lü, S. AU - Wang, J. PY - 2014 DA - 2014// TI - Homoharringtonine and omacetaxine for myeloid hematological malignancies JO - J Hematol Oncol VL - 7 UR - https://doi.org/10.1186/1756-8722-7-2 DO - 10.1186/1756-8722-7-2 ID - Lü2014 ER - TY - JOUR AU - Cortes, J. AU - Digumarti, R. AU - Parikh, P. M. AU - Wetzler, M. AU - Lipton, J. H. AU - Hochhaus, A. AU - Craig, A. R. AU - Benichou, A. C. AU - Nicolini, F. E. AU - Kantarjian, H. M. PY - 2013 DA - 2013// TI - Phase 2 study of subcutaneous omacetaxine mepesuccinate for chronic-phase chronic myeloid leukemia patients resistant to or intolerant of tyrosine kinase inhibitors JO - Am J Hematol VL - 88 UR - https://doi.org/10.1002/ajh.23408 DO - 10.1002/ajh.23408 ID - Cortes2013 ER - TY - JOUR AU - Marin, D. AU - Kaeda, J. S. AU - Andreasson, C. AU - Saunders, S. M. AU - Bua, M. AU - Olavarria, E. AU - Goldman, J. M. AU - Apperley, J. F. PY - 2005 DA - 2005// TI - Phase I/II trial of adding semisynthetic homoharringtonine in chronic myeloid leukemia patients who have achieved partial or complete cytogenetic response on imatinib JO - Cancer VL - 103 UR - https://doi.org/10.1002/cncr.20975 DO - 10.1002/cncr.20975 ID - Marin2005 ER - TY - JOUR AU - Quintas-Cardama, A. AU - Kantarjian, H. AU - Garcia-Manero, G. AU - O'Brien, S. AU - Faderl, S. AU - Estrov, Z. AU - Giles, F. AU - Murgo, A. AU - Ladie, N. AU - Verstovsek, S. AU - Cortes, J. PY - 2007 DA - 2007// TI - Phase I/II study of subcutaneous homoharringtonine in patients with chronic myeloid leukemia who have failed prior therapy JO - Cancer VL - 109 UR - https://doi.org/10.1002/cncr.22398 DO - 10.1002/cncr.22398 ID - Quintas-Cardama2007 ER - TY - JOUR AU - Cortes, J. AU - Lipton, J. H. AU - Rea, D. AU - Digumarti, R. AU - Chuah, C. AU - Nanda, N. AU - Benichou, A. C. AU - Craig, A. R. AU - Michallet, M. AU - Nicolini, F. E. PY - 2012 DA - 2012// TI - Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation JO - Blood VL - 120 UR - https://doi.org/10.1182/blood-2012-03-415307 DO - 10.1182/blood-2012-03-415307 ID - Cortes2012 ER - TY - JOUR AU - O'Brien, S. AU - Kantarjian, H. AU - Koller, C. AU - Feldman, E. AU - Beran, M. AU - Andreeff, M. AU - Giralt, S. AU - Cheson, B. AU - Keating, M. AU - Freireich, E. PY - 1999 DA - 1999// TI - Sequential homoharringtonine and interferon-alpha in the treatment of early chronic phase chronic myelogenous leukemia JO - Blood VL - 93 ID - O'Brien1999 ER - TY - JOUR AU - Nicolini, F. E. AU - Khoury, H. J. AU - Akard, L. AU - Rea, D. AU - Kantarjian, H. AU - Baccarani, M. AU - Leonoudakis, J. AU - Craig, A. AU - Benichou, A. C. AU - Cortes, J. PY - 2013 DA - 2013// TI - Omacetaxine mepesuccinate for patients with accelerated phase chronic myeloid leukemia with resistance or intolerance to two or more tyrosine kinase inhibitors JO - Haematologica VL - 98 UR - https://doi.org/10.3324/haematol.2012.083006 DO - 10.3324/haematol.2012.083006 ID - Nicolini2013 ER - TY - JOUR AU - Nicolini, F. E. AU - Chomel, J. C. AU - Roy, L. AU - Legros, L. AU - Chabane, K. AU - Ducastelle, S. AU - Nicolas-Virelizier, E. AU - Michallet, M. AU - Tigaud, I. AU - Magaud, J. P. PY - 2010 DA - 2010// TI - The durable clearance of the T315I BCR-ABL mutated clone in chronic phase chronic myelogenous leukemia patients on omacetaxine allows tyrosine kinase inhibitor rechallenge JO - Clin Lymphoma Myeloma Leuk VL - 10 UR - https://doi.org/10.3816/CLML.2010.n.073 DO - 10.3816/CLML.2010.n.073 ID - Nicolini2010 ER - TY - JOUR AU - Li, Y. F. AU - Liu, X. AU - Liu, D. S. AU - Din, B. H. AU - Zhu, J. B. PY - 2009 DA - 2009// TI - The effect of homoharringtonine in patients with chronic myeloid leukemia who have failed or responded suboptimally to imatinib therapy JO - Leuk Lymphoma VL - 50 UR - https://doi.org/10.3109/10428190903216838 DO - 10.3109/10428190903216838 ID - Li2009 ER - TY - JOUR AU - Kantarjian, H. M. AU - Talpaz, M. AU - Smith, T. L. AU - Cortes, J. AU - Giles, F. J. AU - Rios, M. B. AU - Mallard, S. AU - Gajewski, J. AU - Murgo, A. AU - Cheson, B. AU - O'Brien, S. PY - 2000 DA - 2000// TI - Homoharringtonine and low-dose cytarabine in the management of late chronic-phase chronic myelogenous leukemia JO - J Clin Oncol VL - 18 UR - https://doi.org/10.1200/JCO.2000.18.20.3513 DO - 10.1200/JCO.2000.18.20.3513 ID - Kantarjian2000 ER - TY - JOUR AU - Stone, R. M. AU - Donohue, K. A. AU - Stock, W. AU - Hars, V. AU - Linker, C. A. AU - Shea, T. AU - Deangelo, D. J. AU - Marcucci, G. AU - Bloomfield, C. D. AU - Larson, R. A. PY - 2009 DA - 2009// TI - A phase II study of continuous infusion homoharringtonine and cytarabine in newly diagnosed patients with chronic myeloid leukemia: CALGB study 19804 JO - Cancer Chemother Pharmacol VL - 63 UR - https://doi.org/10.1007/s00280-008-0805-8 DO - 10.1007/s00280-008-0805-8 ID - Stone2009 ER - TY - JOUR AU - O'Brien, S. AU - Talpaz, M. AU - Cortes, J. AU - Shan, J. AU - Giles, F. J. AU - Faderl, S. AU - Thomas, D. AU - Garcia-Manero, G. AU - Mallard, S. AU - Beth, M. PY - 2002 DA - 2002// TI - Simultaneous homoharringtonine and interferon-alpha in the treatment of patients with chronic-phase chronic myelogenous leukemia JO - Cancer VL - 94 UR - https://doi.org/10.1002/cncr.10436 DO - 10.1002/cncr.10436 ID - O'Brien2002 ER - TY - JOUR AU - O'Brien, S. AU - Giles, F. AU - Talpaz, M. AU - Cortes, J. AU - Rios, M. B. AU - Shan, J. AU - Thomas, D. AU - Andreeff, M. AU - Kornblau, S. AU - Faderl, S. PY - 2003 DA - 2003// TI - Results of triple therapy with interferon-alpha, cytarabine, and homoharringtonine, and the impact of adding imatinib to the treatment sequence in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in early chronic phase JO - Cancer VL - 98 UR - https://doi.org/10.1002/cncr.11620 DO - 10.1002/cncr.11620 ID - O'Brien2003 ER - TY - JOUR AU - Feldman, E. J. AU - Seiter, K. P. AU - Ahmed, T. AU - Baskind, P. AU - Arlin, Z. A. PY - 1996 DA - 1996// TI - Homoharringtonine in patients with myelodysplastic syndrome (MDS) and MDS evolving to acute myeloid leukemia JO - Leukemia VL - 10 ID - Feldman1996 ER - TY - JOUR AU - Daver, N. AU - Vega-Ruiz, A. AU - Kantarjian, H. M. AU - Estrov, Z. AU - Ferrajoli, A. AU - Kornblau, S. AU - Verstovsek, S. AU - Garcia-Manero, G. AU - Cortes, J. E. PY - 2013 DA - 2013// TI - A phase II open-label study of the intravenous administration of homoharringtonine in the treatment of myelodysplastic syndrome JO - Eur J Cancer Care (Engl) VL - 22 UR - https://doi.org/10.1111/ecc.12065 DO - 10.1111/ecc.12065 ID - Daver2013 ER - TY - JOUR AU - Feldman, E. AU - Arlin, Z. AU - Ahmed, T. AU - Mittelman, A. AU - Puccio, C. AU - Chun, H. AU - Cook, P. AU - Baskind, P. PY - 1992 DA - 1992// TI - Homoharringtonine in combination with cytarabine for patients with acute myelogenous leukemia JO - Leukemia VL - 6 ID - Feldman1992 ER - TY - JOUR AU - Zhu, X. AU - Zhang, H. AU - Lin, Y. AU - Chen, P. AU - Min, J. AU - Wang, Z. AU - Xiao, W. AU - Chen, B. PY - 2009 DA - 2009// TI - Mechanisms of gambogic acid-induced apoptosis in non-small cell lung cancer cells in relation to transferrin receptors JO - J Chemother VL - 21 UR - https://doi.org/10.1179/joc.2009.21.6.666 DO - 10.1179/joc.2009.21.6.666 ID - Zhu2009 ER - TY - JOUR AU - Mu, R. AU - Lu, N. AU - Wang, J. AU - Yin, Y. AU - Ding, Y. AU - Zhang, X. AU - Gui, H. AU - Sun, Q. AU - Duan, H. AU - Zhang, L. PY - 2010 DA - 2010// TI - An oxidative analogue of gambogic acid-induced apoptosis of human hepatocellular carcinoma cell line HepG2 is involved in its anticancer activity in vitro JO - Eur J Cancer Prev VL - 19 UR - https://doi.org/10.1097/CEJ.0b013e328333fb22 DO - 10.1097/CEJ.0b013e328333fb22 ID - Mu2010 ER - TY - JOUR AU - McInnes, I. B. AU - Schett, G. PY - 2011 DA - 2011// TI - The pathogenesis of rheumatoid arthritis JO - N Engl J Med VL - 365 UR - https://doi.org/10.1056/NEJMra1004965 DO - 10.1056/NEJMra1004965 ID - McInnes2011 ER - TY - JOUR AU - Zhao, B. AU - Shen, H. AU - Zhang, L. AU - Shen, Y. PY - 2012 DA - 2012// TI - Gambogic acid activates AMP-activated protein kinase in mammalian cells JO - Biochem Biophys Res Commun VL - 424 UR - https://doi.org/10.1016/j.bbrc.2012.06.078 DO - 10.1016/j.bbrc.2012.06.078 ID - Zhao2012 ER - TY - JOUR AU - Shi, X. AU - Chen, X. AU - Li, X. AU - Lan, X. AU - Zhao, C. AU - Liu, S. AU - Huang, H. AU - Liu, N. AU - Liao, S. AU - Song, W. PY - 2014 DA - 2014// TI - Gambogic acid induces apoptosis in imatinib-resistant chronic myeloid leukemia cells via inducing proteasome inhibition and caspase-dependent Bcr-Abl downregulation JO - Clin Cancer Res VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-13-1063 DO - 10.1158/1078-0432.CCR-13-1063 ID - Shi2014 ER - TY - JOUR AU - Sun, H. AU - Chen, F. AU - Wang, X. AU - Liu, Z. AU - Yang, Q. AU - Zhang, X. AU - Zhu, J. AU - Qiang, L. AU - Guo, Q. AU - You, Q. PY - 2012 DA - 2012// TI - Studies on gambogic acid (IV): Exploring structure–activity relationship with IκB kinase-beta (IKKβ) JO - Eur J Med Chem VL - 51 UR - https://doi.org/10.1016/j.ejmech.2012.02.029 DO - 10.1016/j.ejmech.2012.02.029 ID - Sun2012 ER - TY - JOUR AU - Li, G. Y. AU - Yu, X. M. AU - Zhang, H. W. AU - Zhang, B. AU - Wang, C. B. AU - Xin, Y. C. AU - Yang, C. Z. AU - Zhou, R. X. AU - Wang, L. X. PY - 2009 DA - 2009// TI - Haishengsu as an adjunct therapy to conventional chemotherapy in patients with non-small cell lung cancer: a pilot randomized and placebo-controlled clinical trial JO - Complement Ther Med VL - 17 UR - https://doi.org/10.1016/j.ctim.2008.10.002 DO - 10.1016/j.ctim.2008.10.002 ID - Li2009 ER - TY - JOUR AU - Liu, J. Z. AU - Chen, S. G. AU - Zhang, B. AU - Wang, C. B. AU - Zhao, X. W. AU - Li, G. Y. AU - Wang, L. X. PY - 2009 DA - 2009// TI - Effect of haishengsu as an adjunct therapy for patients with advanced renal cell cancer: a randomized and placebo-controlled clinical trial JO - J Altern Complement Med VL - 15 UR - https://doi.org/10.1089/acm.2009.0260 DO - 10.1089/acm.2009.0260 ID - Liu2009 ER - TY - JOUR AU - Li, G. Y. AU - Liu, J. Z. AU - Zhang, B. AU - Yang, M. AU - Chen, S. G. AU - Hou, M. AU - Wang, L. X. PY - 2013 DA - 2013// TI - Tegillarca granosa extract Haishengsu (HSS) suppresses expression of mdr1, BCR/ABL and sorcin in drug-resistant K562/ADM tumors in mice JO - Adv Med Sci VL - 58 UR - https://doi.org/10.2478/v10039-012-0069-8 DO - 10.2478/v10039-012-0069-8 ID - Li2013 ER - TY - JOUR AU - Shi, X. AU - Jin, Y. AU - Cheng, C. AU - Zhang, H. AU - Zou, W. AU - Zheng, Q. AU - Lu, Z. AU - Chen, Q. AU - Lai, Y. AU - Pan, J. PY - 2009 DA - 2009// TI - Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-08-2141 DO - 10.1158/1078-0432.CCR-08-2141 ID - Shi2009 ER - TY - JOUR AU - Zhou, Z. -. L. AU - Yang, Y. -. X. AU - Ding, J. AU - Li, Y. -. C. AU - Miao, Z. -. H. PY - 2012 DA - 2012// TI - Triptolide: structural modifications, structure–activity relationships, bioactivities, clinical development and mechanisms JO - Nat Prod Rep VL - 29 UR - https://doi.org/10.1039/c2np00088a DO - 10.1039/c2np00088a ID - Zhou2012 ER - TY - JOUR AU - William, B. M. AU - Goodrich, A. AU - Peng, C. AU - Li, S. PY - 2008 DA - 2008// TI - Curcumin inhibits proliferation and induces apoptosis of leukemic cells expressing wild-type or T315I-BCR-ABL and prolongs survival of mice with acute lymphoblastic leukemia JO - Hematology VL - 13 UR - https://doi.org/10.1179/102453308X343437 DO - 10.1179/102453308X343437 ID - William2008 ER - TY - JOUR AU - Priyadarsini, K. I. AU - Maity, D. K. AU - Naik, G. AU - Kumar, M. S. AU - Unnikrishnan, M. AU - Satav, J. AU - Mohan, H. PY - 2003 DA - 2003// TI - Role of phenolic OH and methylene hydrogen on the free radical reactions and antioxidant activity of curcumin JO - Free Radic Biol Med VL - 35 UR - https://doi.org/10.1016/S0891-5849(03)00325-3 DO - 10.1016/S0891-5849(03)00325-3 ID - Priyadarsini2003 ER - TY - STD TI - Yang H, Du Z, Wang W, Song M, Sanidad KZ, Sukamtoh E, Zheng J, Tian L, Xiao H, Liu Z. Structure and Activity Relationship of Curcumin: Role of Methoxy Group in Anti-inflammatory and Anti-colitis Effects of Curcumin. J Agric Food Chem. 2017;65:4509–15. ID - ref218 ER - TY - JOUR AU - Chai, S. AU - Lin, G. PY - 2010 DA - 2010// TI - Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines JO - Chin Med VL - 5 UR - https://doi.org/10.1186/1749-8546-5-26 DO - 10.1186/1749-8546-5-26 ID - Chai2010 ER - TY - JOUR AU - Wei, Y. L. AU - Xu, L. AU - Liang, Y. AU - Xu, X. H. AU - Zhao, X. Y. PY - 2009 DA - 2009// TI - Berbamine exhibits potent antitumor effects on imatinib-resistant CML cells in vitro and in vivo JO - Acta Pharmacol Sin VL - 30 UR - https://doi.org/10.1038/aps.2009.19 DO - 10.1038/aps.2009.19 ID - Wei2009 ER - TY - JOUR AU - Karnam, K. C. AU - Ellutla, M. AU - Bodduluru, L. N. AU - Kasala, E. R. AU - Uppulapu, S. K. AU - Kalyankumarraju, M. AU - Lahkar, M. PY - 2017 DA - 2017// TI - Preventive effect of berberine against DMBA-induced breast cancer in female Sprague Dawley rats JO - Biomed Pharmacother VL - 92 UR - https://doi.org/10.1016/j.biopha.2017.05.069 DO - 10.1016/j.biopha.2017.05.069 ID - Karnam2017 ER - TY - JOUR AU - Nam, S. AU - Xie, J. AU - Perkins, A. AU - Ma, Y. AU - Yang, F. AU - Wu, J. AU - Wang, Y. AU - Xu, R. Z. AU - Huang, W. AU - Horne, D. A. AU - Jove, R. PY - 2012 DA - 2012// TI - Novel synthetic derivatives of the natural product berbamine inhibit Jak2/Stat3 signaling and induce apoptosis of human melanoma cells JO - Mol Oncol VL - 6 UR - https://doi.org/10.1016/j.molonc.2012.05.002 DO - 10.1016/j.molonc.2012.05.002 ID - Nam2012 ER - TY - JOUR AU - Zhang, Y. F. AU - Xu, G. B. AU - Gan, Y. C. AU - Xu, X. H. AU - Xu, R. Z. PY - 2011 DA - 2011// TI - Inhibitory effect of 4-chlorobenzoyl berbamine on imatinib-resistant K562 cells in vitro and in vivo JO - Nan Fang Yi Ke Da Xue Xue Bao VL - 31 ID - Zhang2011 ER - TY - JOUR AU - Wei, Y. L. AU - Liang, Y. AU - Xu, L. AU - Zhao, X. Y. PY - 2009 DA - 2009// TI - The antiproliferation effect of berbamine on k562 resistant cells by inhibiting NF-kappaB pathway JO - Anat Rec (Hoboken) VL - 292 UR - https://doi.org/10.1002/ar.20924 DO - 10.1002/ar.20924 ID - Wei2009 ER - TY - JOUR AU - Xu, X. H. AU - Gan, Y. C. AU - Xu, G. B. AU - Chen, T. AU - Zhou, H. AU - Tang, J. F. AU - Gu, Y. AU - Xu, F. AU - Xie, Y. Y. AU - Zhao, X. Y. AU - Xu, R. Z. PY - 2012 DA - 2012// TI - Tetrandrine citrate eliminates imatinib-resistant chronic myeloid leukemia cells in vitro and in vivo by inhibiting Bcr-Abl/beta-catenin axis JO - J Zhejiang Univ Sci B VL - 13 UR - https://doi.org/10.1631/jzus.B1200021 DO - 10.1631/jzus.B1200021 ID - Xu2012 ER - TY - JOUR AU - Leung, Y. M. AU - Berdik, M. AU - Kwan, C. Y. AU - Loh, T. T. PY - 1996 DA - 1996// TI - Effects of tetrandrine and closely related bis-benzylisoquinoline derivatives on cytosolic Ca2+ in human leukaemic HL-60 cells: a structure-activity relationship study JO - Clin Exp Pharmacol Physiol VL - 23 UR - https://doi.org/10.1111/j.1440-1681.1996.tb01752.x DO - 10.1111/j.1440-1681.1996.tb01752.x ID - Leung1996 ER - TY - JOUR AU - Li, X. AU - Miao, H. AU - Zhang, Y. AU - Li, W. AU - Li, Z. AU - Zhou, Y. AU - Zhao, L. AU - Guo, Q. PY - 2015 DA - 2015// TI - Bone marrow microenvironment confers imatinib resistance to chronic myelogenous leukemia and oroxylin A reverses the resistance by suppressing Stat3 pathway JO - Arch Toxicol VL - 89 UR - https://doi.org/10.1007/s00204-014-1226-6 DO - 10.1007/s00204-014-1226-6 ID - Li2015 ER - TY - JOUR AU - Bandyopadhyay, G. AU - Biswas, T. AU - Roy, K. C. AU - Mandal, S. AU - Mandal, C. AU - Pal, B. C. AU - Bhattacharya, S. AU - Rakshit, S. AU - Bhattacharya, D. K. AU - Chaudhuri, U. PY - 2004 DA - 2004// TI - Chlorogenic acid inhibits Bcr-Abl tyrosine kinase and triggers p38 mitogen-activated protein kinase-dependent apoptosis in chronic myelogenous leukemic cells JO - Blood VL - 104 UR - https://doi.org/10.1182/blood-2003-11-4065 DO - 10.1182/blood-2003-11-4065 ID - Bandyopadhyay2004 ER - TY - JOUR AU - Lu, Z. AU - Jin, Y. AU - Qiu, L. AU - Lai, Y. AU - Pan, J. PY - 2010 DA - 2010// TI - Celastrol, a novel HSP90 inhibitor, depletes Bcr-Abl and induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation JO - Cancer Lett VL - 290 UR - https://doi.org/10.1016/j.canlet.2009.09.006 DO - 10.1016/j.canlet.2009.09.006 ID - Lu2010 ER - TY - JOUR AU - Lu, Z. AU - Jin, Y. AU - Chen, C. AU - Li, J. AU - Cao, Q. AU - Pan, J. PY - 2010 DA - 2010// TI - Pristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation by blocking NF-kappaB signaling and depleting Bcr-Abl JO - Mol Cancer VL - 9 UR - https://doi.org/10.1186/1476-4598-9-112 DO - 10.1186/1476-4598-9-112 ID - Lu2010 ER - TY - JOUR AU - Honma, Y. AU - Okabe-Kado, J. AU - Hozumi, M. AU - Uehara, Y. AU - Mizuno, S. PY - 1989 DA - 1989// TI - Induction of erythroid differentiation of K562 human leukemic cells by herbimycin A, an inhibitor of tyrosine kinase activity JO - Cancer Res VL - 49 ID - Honma1989 ER - TY - JOUR AU - Honma, Y. AU - Okabe-Kado, J. AU - Kasukabe, T. AU - Hozumi, M. AU - Kodama, H. AU - Kajigaya, S. AU - Suda, T. AU - Miura, Y. PY - 1992 DA - 1992// TI - Herbimycin A, an inhibitor of tyrosine kinase, prolongs survival of mice inoculated with myeloid leukemia C1 cells with high expression of v-abl tyrosine kinase JO - Cancer Res VL - 52 ID - Honma1992 ER - TY - JOUR AU - Honma, Y. AU - Okabe-Kado, J. AU - Kasukabe, T. AU - Hozumi, M. AU - Kajigaya, S. AU - Suda, T. AU - Miura, Y. PY - 1991 DA - 1991// TI - Induction by some protein kinase inhibitors of differentiation of a mouse megakaryoblastic cell line established by coinfection with Abelson murine leukemia virus and recombinant SV40 retrovirus JO - Cancer Res VL - 51 ID - Honma1991 ER - TY - JOUR AU - Sato, S. AU - Honma, Y. AU - Hozumi, M. AU - Hayashi, Y. AU - Matsuo, Y. AU - Shibata, K. AU - Omura, S. AU - Hino, K. AU - Tomoyasu, S. AU - Tsuruoka, N. PY - 1994 DA - 1994// TI - Effects of herbimycin A and its derivatives on growth and differentiation of Ph1-positive acute lymphoid leukemia cell lines JO - Leuk Res VL - 18 UR - https://doi.org/10.1016/0145-2126(94)90118-X DO - 10.1016/0145-2126(94)90118-X ID - Sato1994 ER - TY - JOUR AU - Liu, M. J. AU - Wang, Z. AU - Li, H. X. AU - Wu, R. C. AU - Liu, Y. Z. AU - Wu, Q. Y. PY - 2004 DA - 2004// TI - Mitochondrial dysfunction as an early event in the process of apoptosis induced by woodfordin I in human leukemia K562 cells JO - Toxicol Appl Pharmacol VL - 194 UR - https://doi.org/10.1016/j.taap.2003.08.017 DO - 10.1016/j.taap.2003.08.017 ID - Liu2004 ER - TY - JOUR AU - Huang, Y. C. AU - Guh, J. H. AU - Teng, C. M. PY - 2005 DA - 2005// TI - Denbinobin-mediated anticancer effect in human K562 leukemia cells: role in tubulin polymerization and Bcr-Abl activity JO - J Biomed Sci VL - 12 UR - https://doi.org/10.1007/s11373-004-8171-y DO - 10.1007/s11373-004-8171-y ID - Huang2005 ER - TY - JOUR AU - Guo, Y. AU - Shan, Q. AU - Gong, Y. AU - Lin, J. AU - Yang, X. AU - Zhou, R. PY - 2012 DA - 2012// TI - Oridonin in combination with imatinib exerts synergetic anti-leukemia effect in Ph+ acute lymphoblastic leukemia cells in vitro by inhibiting activation of LYN/mTOR signaling pathway JO - Cancer Biol Ther VL - 13 UR - https://doi.org/10.4161/cbt.21460 DO - 10.4161/cbt.21460 ID - Guo2012 ER - TY - JOUR AU - Kamei, H. AU - Koide, T. AU - Kojimam, T. AU - Hasegawa, M. AU - Terabe, K. AU - Umeda, T. AU - Hashimoto, Y. PY - 1996 DA - 1996// TI - Flavonoid-mediated tumor growth suppression demonstrated by in vivo study JO - Cancer Biother Radiopharm VL - 11 UR - https://doi.org/10.1089/cbr.1996.11.193 DO - 10.1089/cbr.1996.11.193 ID - Kamei1996 ER - TY - JOUR AU - Caltagirone, S. AU - Rossi, C. AU - Poggi, A. AU - Ranelletti, F. O. AU - Natali, P. G. AU - Brunetti, M. AU - Aiello, F. B. AU - Piantelli, M. PY - 2000 DA - 2000// TI - Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential JO - Int J Cancer VL - 87 UR - https://doi.org/3.0.CO;2-5 DO - 3.0.CO;2-5 ID - Caltagirone2000 ER - TY - JOUR AU - Can, G. AU - Cakir, Z. AU - Kartal, M. AU - Gunduz, U. AU - Baran, Y. PY - 2012 DA - 2012// TI - Apoptotic effects of resveratrol, a grape polyphenol, on imatinib-sensitive and resistant K562 chronic myeloid leukemia cells JO - Anticancer Res VL - 32 ID - Can2012 ER - TY - JOUR AU - Wu, X. -. p. AU - Xiong, M. AU - Xu, C. -. S. AU - Duan, L. -. N. AU - Dong, Y. -. Q. AU - Luo, Y. AU - Niu, T. -. H. AU - Lu, C. -. R. PY - 2015 DA - 2015// TI - Resveratrol induces apoptosis of human chronic myelogenous leukemia cells in vitro through p38 and JNK-regulated H2AX phosphorylation JO - Acta Pharmacol Sin VL - 36 UR - https://doi.org/10.1038/aps.2014.132 DO - 10.1038/aps.2014.132 ID - Wu2015 ER - TY - JOUR AU - Solmaz, S. AU - Adan Gokbulut, A. AU - Cincin, B. AU - Ozdogu, H. AU - Boga, C. AU - Cakmakoglu, B. AU - Kozanoglu, I. AU - Baran, Y. PY - 2014 DA - 2014// TI - Therapeutic potential of apigenin, a plant flavonoid, for imatinib-sensitive and resistant chronic myeloid leukemia cells JO - Nutr Cancer VL - 66 UR - https://doi.org/10.1080/01635581.2014.894099 DO - 10.1080/01635581.2014.894099 ID - Solmaz2014 ER - TY - JOUR AU - Angulo, P. AU - Kaushik, G. AU - Subramaniam, D. AU - Dandawate, P. AU - Neville, K. AU - Chastain, K. AU - Anant, S. PY - 2017 DA - 2017// TI - Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapy JO - J Hematol Oncol VL - 10 UR - https://doi.org/10.1186/s13045-016-0373-z DO - 10.1186/s13045-016-0373-z ID - Angulo2017 ER - TY - JOUR AU - Adan, A. AU - Baran, Y. PY - 2016 DA - 2016// TI - Fisetin and hesperetin induced apoptosis and cell cycle arrest in chronic myeloid leukemia cells accompanied by modulation of cellular signaling JO - Tumour Biol VL - 37 UR - https://doi.org/10.1007/s13277-015-4118-3 DO - 10.1007/s13277-015-4118-3 ID - Adan2016 ER - TY - JOUR AU - Zhang, G. AU - Li, M. AU - Han, S. AU - Chen, D. AU - Wang, Y. AU - Ye, W. AU - Ji, Z. PY - 2014 DA - 2014// TI - Induction of human chronic myeloid leukemia K562 cell apoptosis by virosecurinine and its molecular mechanism JO - Mol Med Rep VL - 10 UR - https://doi.org/10.3892/mmr.2014.2531 DO - 10.3892/mmr.2014.2531 ID - Zhang2014 ER - TY - JOUR AU - Ambrosino, D. M. AU - Siber, G. R. AU - Chilmonczyk, B. A. AU - Jernberg, J. B. AU - Finberg, R. W. PY - 1987 DA - 1987// TI - An immunodeficiency characterized by impaired antibody responses to polysaccharides JO - N Engl J Med VL - 316 UR - https://doi.org/10.1056/NEJM198703263161306 DO - 10.1056/NEJM198703263161306 ID - Ambrosino1987 ER - TY - JOUR AU - Deora, A. B. AU - Miranda, M. B. AU - Rao, S. G. PY - 1997 DA - 1997// TI - Down-modulation of P210bcr/abl induces apoptosis/differentiation in K562 leukemic blast cells JO - Tumori VL - 83 ID - Deora1997 ER - TY - JOUR AU - Scappini, B. AU - Onida, F. AU - Kantarjian, H. M. AU - Dong, L. AU - Verstovsek, S. AU - Keating, M. J. AU - Beran, M. PY - 2002 DA - 2002// TI - In vitro effects of STI 571-containing drug combinations on the growth of Philadelphia-positive chronic myelogenous leukemia cells JO - Cancer VL - 94 UR - https://doi.org/10.1002/cncr.10543 DO - 10.1002/cncr.10543 ID - Scappini2002 ER - TY - JOUR AU - Kano, Y. AU - Akutsu, M. AU - Tsunoda, S. AU - Mano, H. AU - Sato, Y. AU - Honma, Y. AU - Furukawa, Y. PY - 2001 DA - 2001// TI - In vitro cytotoxic effects of a tyrosine kinase inhibitor STI571 in combination with commonly used antileukemic agents JO - Blood VL - 97 UR - https://doi.org/10.1182/blood.V97.7.1999 DO - 10.1182/blood.V97.7.1999 ID - Kano2001 ER -